hg_109178.1

Basic information about the TSS

---

TSS ID: hg_109178.1 Species: human Chr: chr10		Start: 43397220 End: 43397314 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000477108.5 BC106008 Distance: 0 GeneID: 3185 HGNC/MGI_ID: HGNC:5039 UniProt_ID: A0A1B0GW42

Gene_name: heterogeneous nuclear ribonucleoprotein F Gene_symbol: HNRNPF Gene_synonyms: Gene_source: HGNC:5039

TATA-Box annotation

---

Distance to TSS:	79
Nearest PromoterID:	NM_001098207
Entrez ID:	3185
Nearest Unigene:	Hs.808
Nearest Refseq:	NM_004966
Nearest Ensembl:	ENSG00000169813
Gene Name:	heterogeneous nuclear ribonucleoprotein F
Gene Alias:	HNRPF|OK/SW-cl.23|mcs94-1
Gene Description:	heterogeneous nuclear ribonucleoprotein F
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.731343
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HNRNPF p2@HNRNPF p3@HNRNPF p4@HNRNPF p5@HNRNPF p6@HNRNPF p7@HNRNPF p8@HNRNPF p9@HNRNPF p10@HNRNPF
Sample		p1@HNRNPF	p2@HNRNPF	p3@HNRNPF	p4@HNRNPF	p5@HNRNPF	p6@HNRNPF	p7@HNRNPF	p8@HNRNPF	p9@HNRNPF	p10@HNRNPF
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	81.04	106.95	20.84	19.09	4.87	3.51	1.75	0.19	0.58	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	94.69	100.15	19.02	22.05	4.25	3.64	2.43	1.01	0.40	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	88.74	112.66	17.17	20.25	8.49	4.05	0.96	0.77	1.35	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	84.00	112.27	18.30	15.18	5.41	3.12	2.29	0.21	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	85.26	109.56	18.67	15.52	6.07	5.62	1.35	0.22	0.00	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	88.38	99.04	14.92	12.79	5.23	5.23	1.16	0.58	0.78	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	84.54	104.37	17.21	18.96	8.06	3.92	1.96	0.87	1.09	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	73.39	86.71	13.81	12.84	5.09	2.91	1.21	0.97	0.24	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	74.59	86.34	15.17	18.59	4.27	1.92	1.92	0.43	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	67.24	71.87	16.81	26.08	10.43	4.06	5.22	0.00	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	58.61	74.78	21.83	28.30	12.53	3.23	2.43	0.40	0.40	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	55.29	70.74	17.48	26.43	9.35	4.07	1.22	0.81	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	33.53	21.92	15.31	10.48	1.29	1.61	0.32	0.00	1.29	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	29.32	22.25	10.98	5.26	1.35	1.35	0.45	0.45	1.05	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	34.69	17.13	10.98	8.34	0.22	1.10	0.00	0.22	1.54	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	34.20	21.88	15.09	9.05	0.50	2.26	0.25	0.25	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.89	22.71	12.67	6.77	0.66	1.31	0.22	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.42	16.45	18.14	8.01	0.84	0.84	0.42	1.27	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	20.79	20.26	13.33	4.80	0.53	2.13	0.00	0.00	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.05	23.02	15.65	9.93	1.20	2.26	0.15	0.60	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	40.50	22.32	16.57	12.96	1.87	2.00	0.53	0.67	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	41.60	23.82	15.19	6.90	0.86	2.93	0.00	0.52	1.90	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	37.48	22.49	13.44	8.14	1.29	2.46	0.13	0.78	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	36.64	25.24	13.83	11.16	0.97	2.43	0.00	0.97	0.97	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	41.54	25.54	14.19	11.61	1.55	2.32	0.52	0.77	1.55	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	36.40	19.31	15.51	8.86	0.95	3.17	0.00	0.32	3.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	33.52	21.43	14.29	12.64	0.00	3.85	0.55	0.00	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	41.49	24.99	17.92	10.61	1.65	2.59	0.71	0.94	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	39.25	22.45	14.38	12.44	1.13	2.10	0.97	0.65	1.78	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	42.35	18.82	18.46	11.22	1.63	2.71	0.36	0.36	1.09	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	30.98	20.10	20.31	11.72	1.88	1.67	0.42	0.00	3.14	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	37.12	16.61	13.68	11.53	1.56	2.34	0.39	0.78	1.37	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	37.56	19.63	15.41	12.66	1.69	3.17	0.00	0.63	2.11	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	46.18	23.59	9.90	5.77	2.14	3.30	1.15	0.33	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	39.83	19.07	13.84	10.10	1.12	0.93	0.93	0.56	2.06	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	38.71	21.27	16.10	11.31	0.96	3.64	0.19	0.77	1.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	45.58	19.21	15.94	11.65	2.04	2.45	0.00	0.41	2.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	37.07	14.91	15.11	9.67	1.01	3.02	0.20	0.81	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	34.03	11.61	18.64	10.26	1.62	1.62	0.54	0.27	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	36.01	15.84	14.16	15.60	0.96	1.92	0.48	0.48	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	42.58	16.70	10.35	14.82	0.94	3.06	0.24	0.94	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	45.68	19.18	9.95	7.47	1.32	1.90	0.00	0.88	2.05	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	40.07	21.93	14.13	19.61	0.84	1.69	0.84	0.63	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	40.91	17.66	13.29	16.96	0.35	2.27	0.17	0.35	1.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	39.55	20.08	12.85	14.86	1.20	2.41	0.40	0.60	1.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	35.59	15.12	15.59	14.89	0.93	2.09	0.23	0.47	1.63	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	37.67	17.99	17.99	17.99	0.72	1.68	0.24	0.24	1.44	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	33.38	14.01	9.24	17.58	0.60	2.09	0.30	0.30	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	42.13	18.67	12.69	15.80	0.24	1.68	0.48	0.96	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	36.80	14.96	10.51	17.39	1.21	1.01	0.40	0.61	2.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	34.64	16.19	12.91	20.29	1.23	1.23	1.02	0.00	1.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	41.36	19.57	15.34	20.01	1.56	1.33	0.44	0.44	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	97.95	13.99	13.99	0.00	0.00	0.00	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	31.94	18.81	12.07	20.23	2.13	1.42	0.00	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	32.14	18.56	11.27	16.24	0.99	0.66	0.00	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	43.62	24.33	8.39	3.36	0.00	0.84	2.52	1.68	6.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	39.49	21.13	5.51	5.51	0.00	0.92	0.92	0.92	2.76	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	43.11	19.45	10.05	14.58	0.00	0.65	0.32	1.30	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	31.80	17.66	14.77	18.63	1.28	0.32	0.00	0.32	2.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	33.00	20.43	8.49	3.14	2.83	1.57	0.31	0.94	1.57	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	25.38	11.28	14.10	18.33	2.82	0.00	0.71	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	40.38	14.58	7.85	11.22	1.12	0.56	0.56	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	16.72	13.53	7.17	3.18	2.39	1.59	0.80	0.00	5.57	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	30.92	12.91	9.51	4.76	1.70	0.68	0.68	1.02	2.04	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	41.59	19.82	16.90	15.27	2.92	0.00	0.32	0.32	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	32.30	15.26	13.84	15.26	1.06	0.00	0.00	0.00	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	129.31	16.16	16.16	0.00	0.00	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	7.90	0.00	7.90	0.00	0.00	7.90	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	30.23	26.81	8.78	15.60	0.49	0.49	1.46	0.98	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.22	23.80	7.93	7.44	0.50	0.50	1.49	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	29.55	25.33	9.85	6.10	1.41	0.47	0.00	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	39.08	25.17	10.93	1.66	0.66	0.66	0.66	0.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	34.65	29.70	14.23	10.52	0.31	0.00	0.93	0.62	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.05	25.68	13.45	11.31	1.22	0.31	0.61	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	35.48	21.70	6.02	4.12	0.48	1.11	0.16	0.32	0.79	0.16
Adipocyte - breast, donor2	11327-117E4	34.81	22.78	7.86	3.37	0.32	0.48	0.96	1.12	1.28	0.96
Adipocyte - omental, donor1	11473-119C6	33.84	19.72	4.58	1.91	0.25	0.13	0.38	0.38	0.64	0.00
Adipocyte - omental, donor2	11474-119C7	35.88	20.93	4.48	1.49	0.00	0.00	1.49	0.00	0.75	1.49
Adipocyte - omental, donor3	11475-119C8	23.11	20.76	6.03	1.34	0.00	0.33	0.67	0.33	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	33.18	20.42	5.10	3.19	0.64	0.00	0.64	0.64	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	17.59	9.90	2.20	1.10	0.00	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	37.48	39.74	3.16	1.35	1.81	0.45	0.45	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	39.27	27.63	2.78	1.04	0.35	0.35	0.35	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	66.30	44.00	11.15	3.32	0.39	0.98	0.39	0.00	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	35.00	27.02	9.78	4.63	0.77	0.26	0.26	0.00	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	38.19	37.36	9.48	4.18	1.67	0.56	0.00	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	32.33	22.34	9.99	3.53	0.59	0.59	0.00	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	41.26	27.19	6.27	4.18	0.08	1.05	0.24	0.24	0.40	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	35.18	35.18	6.46	4.52	0.97	1.61	0.65	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	36.26	26.66	8.53	3.73	0.00	3.20	1.07	0.00	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	25.04	25.04	6.68	3.34	0.00	0.56	1.11	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	33.27	17.05	8.32	3.33	0.00	0.00	0.83	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	31.90	27.63	9.80	1.51	0.50	2.51	0.25	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	28.47	20.29	6.54	2.95	0.00	2.62	0.33	0.00	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	22.53	10.96	7.31	2.74	0.00	1.83	0.00	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	52.60	45.30	9.94	15.69	3.09	0.00	0.22	0.44	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	31.91	38.01	10.04	15.42	1.43	1.08	1.08	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	22.76	28.75	14.38	9.58	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	67.28	47.50	12.41	19.61	1.26	0.36	0.36	0.18	1.26	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	35.14	28.45	13.39	16.73	0.00	0.00	1.67	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	57.53	31.23	10.48	16.64	0.62	0.21	1.03	0.21	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	44.74	47.03	7.32	6.18	0.69	0.11	0.57	0.34	0.11	0.11
Anulus Pulposus Cell, donor2	11463-119B5	29.39	33.06	10.53	7.59	0.98	0.49	1.71	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	33.25	16.62	6.29	3.15	0.45	0.00	0.90	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	29.96	21.71	8.68	3.04	0.00	0.43	0.87	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	17.12	8.56	0.00	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	36.17	17.04	4.18	4.48	1.20	0.30	0.90	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	40.47	21.50	2.53	2.53	1.26	0.00	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.76	11.88	5.94	9.24	0.00	0.00	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	35.09	13.32	8.12	5.52	0.97	0.65	1.30	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	38.84	14.08	7.77	3.88	0.97	0.49	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	29.10	17.22	5.94	4.16	0.00	0.00	0.59	0.00	0.00	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	38.42	12.81	7.91	4.90	1.13	0.00	1.88	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.03	15.24	6.53	2.90	0.73	0.00	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	25.08	26.33	11.28	2.51	1.25	0.00	0.00	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.01	17.63	6.10	6.26	0.16	0.33	0.49	0.00	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	42.31	19.11	5.46	2.73	0.00	1.36	4.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	33.63	18.09	6.48	5.43	0.45	0.45	0.30	0.00	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	31.08	22.50	5.36	4.82	0.00	1.07	0.54	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	31.93	17.38	5.29	4.53	0.19	0.19	1.13	0.00	0.19	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	29.94	22.18	6.68	5.08	1.07	1.07	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	32.19	13.66	5.85	4.88	0.98	0.00	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	31.02	19.07	4.64	3.81	0.50	0.17	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	15.61	3.60	2.40	0.00	0.00	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	28.32	7.08	3.54	0.00	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	31.90	16.12	6.69	5.83	0.17	0.34	0.86	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	29.36	0.00	12.58	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	30.58	16.50	8.25	4.85	0.00	0.97	1.94	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	29.22	17.08	6.45	7.21	0.00	0.00	0.38	0.38	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	8.48	4.85	4.85	1.21	0.00	2.42	0.00	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	39.90	15.39	5.70	3.42	0.57	0.00	1.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	28.00	15.18	7.48	6.63	0.00	0.21	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	22.71	12.90	8.00	6.71	0.00	0.52	0.77	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	29.56	18.30	5.63	7.04	0.94	0.00	0.94	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	28.62	15.76	6.43	5.79	0.00	0.00	1.29	0.64	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	28.54	16.41	4.28	4.99	0.71	0.00	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	31.59	18.13	5.26	5.26	0.58	0.58	0.58	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.41	17.16	6.32	7.23	0.30	0.30	1.20	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	21.38	14.26	3.56	3.56	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.99	22.38	6.10	3.56	0.51	0.00	1.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.80	18.08	7.39	5.35	0.00	0.25	0.76	0.51	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	26.69	11.44	6.35	3.18	0.64	0.00	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	30.21	14.67	6.04	4.32	0.00	0.43	1.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	30.48	15.24	5.29	4.02	0.42	0.21	0.42	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	28.71	17.98	8.12	8.12	0.87	0.00	0.58	0.00	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	25.51	10.39	9.45	3.78	0.00	0.00	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	26.95	14.92	5.59	6.27	0.34	0.17	0.51	0.17	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	32.43	13.90	6.95	2.32	0.00	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	10.56	10.56	6.34	0.00	0.00	0.00	2.11	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	25.73	19.73	6.00	4.93	0.64	0.43	0.00	0.00	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	31.29	16.24	8.42	4.21	1.80	0.60	0.60	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	34.26	22.60	9.48	2.92	0.73	0.00	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	30.11	19.31	3.91	3.68	0.23	0.46	0.23	0.00	0.00	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	22.95	5.10	10.20	2.55	0.00	2.55	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	32.03	18.05	5.59	2.03	0.51	0.51	0.00	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.44	17.13	7.64	5.99	0.41	0.62	1.24	0.21	0.00	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	23.87	15.61	8.57	3.67	0.31	0.61	0.31	0.61	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	34.89	17.69	7.17	4.78	0.00	0.48	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	33.26	14.63	6.43	6.21	0.22	0.00	1.55	0.22	0.00	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	27.46	10.68	4.58	3.05	0.00	0.00	1.53	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	37.11	14.95	8.31	3.32	0.55	0.00	0.00	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	29.39	13.24	7.41	4.77	1.06	0.00	0.26	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	26.90	14.17	5.09	4.00	0.00	0.36	0.73	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	68.04	59.20	17.44	18.55	6.75	0.86	0.49	0.12	0.98	0.25
Astrocyte - cerebellum, donor2	11580-120F5	62.82	37.14	9.24	19.00	3.25	0.17	1.20	0.51	0.51	0.17
Astrocyte - cerebellum, donor3	11661-122F5	41.95	28.95	8.60	10.70	1.68	0.63	0.21	0.00	0.63	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	91.33	49.85	13.59	21.61	8.71	1.05	1.05	0.00	2.09	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	86.23	54.03	17.31	34.30	6.47	0.16	3.24	0.65	0.81	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	103.82	59.37	11.93	29.09	12.23	0.60	1.94	0.60	0.45	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	161.59	130.97	51.84	16.06	5.85	2.98	7.91	3.33	0.46	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	180.41	151.09	48.48	18.92	10.15	2.76	5.64	5.01	0.13	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	163.18	126.31	49.50	20.14	8.19	2.96	6.26	2.73	0.80	1.25
Basophils, donor1	12241-129G9	46.29	26.41	27.98	7.06	19.35	15.95	0.26	0.00	0.00	0.26
Basophils, donor2	12242-129H1	55.20	34.64	25.62	8.30	15.87	14.43	0.00	0.00	0.72	0.36
Basophils, donor3	12243-129H2	51.01	25.58	23.96	6.32	12.94	14.85	0.44	0.00	0.44	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	29.97	43.55	1.94	2.37	0.65	0.00	0.43	0.22	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	21.03	26.52	5.49	4.57	0.46	0.00	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	93.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	37.66	49.58	6.90	6.28	2.51	0.63	1.26	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	47.83	48.87	6.65	7.07	1.25	0.42	0.21	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	26.71	34.08	4.38	2.07	0.23	0.23	1.15	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	40.67	46.79	6.30	4.14	1.80	0.00	1.80	0.00	0.00	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	163.96	86.26	26.59	0.00	13.40	1.24	0.72	0.62	1.24	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	117.15	58.23	9.08	1.40	17.70	0.23	0.00	0.00	1.86	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	103.93	70.99	26.22	4.80	21.42	4.48	0.32	0.64	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	41.37	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	39.45	25.92	23.11	1.13	15.22	16.91	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	37.12	21.16	30.44	5.75	13.18	18.00	0.19	0.56	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	43.47	18.22	19.98	5.05	32.49	15.81	0.88	0.22	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	83.78	62.27	36.51	5.94	0.85	7.36	0.28	0.00	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	66.34	50.42	21.23	7.58	0.76	8.72	0.00	0.38	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	75.28	54.24	32.22	7.89	0.33	7.89	0.33	0.00	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	79.36	34.26	66.64	4.77	2.60	9.97	2.17	0.87	0.43	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	58.84	37.11	41.04	1.81	2.72	13.88	0.91	0.91	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	60.41	30.32	41.93	4.26	3.79	11.13	1.18	0.47	0.24	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	55.07	23.10	55.24	3.52	3.18	15.40	1.00	0.67	0.67	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	53.82	28.43	42.23	4.97	1.10	21.53	0.83	0.55	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	59.01	40.66	53.30	1.49	6.20	34.21	0.99	0.25	1.49	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	64.81	109.84	70.88	2.55	4.31	16.45	3.13	1.37	0.59	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	53.59	80.30	47.00	5.52	1.25	20.12	0.89	1.07	0.53	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	72.04	134.50	52.23	2.18	4.13	21.55	1.52	1.74	0.65	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	69.77	25.52	68.36	3.98	5.15	27.86	2.34	0.00	0.94	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	60.72	27.46	49.63	5.28	2.11	33.79	0.00	0.00	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	88.75	33.28	63.23	1.11	13.31	27.73	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	59.80	26.48	61.58	4.76	3.12	11.01	1.64	0.59	1.19	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	55.87	32.73	46.49	4.39	2.00	16.36	0.40	0.20	0.80	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	70.16	33.52	41.43	2.29	3.33	8.12	1.04	0.42	0.83	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	67.26	30.89	66.12	5.03	6.18	19.90	1.37	0.46	0.92	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	55.87	23.98	45.92	2.71	2.71	27.37	1.13	0.45	0.90	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	54.56	22.70	49.76	2.18	4.80	24.01	2.18	0.87	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	65.63	119.70	46.27	3.23	4.57	8.07	2.15	0.54	0.81	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	67.52	122.65	43.62	5.23	3.31	13.08	2.09	0.52	0.70	1.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	66.91	127.09	49.66	2.10	4.21	8.42	0.84	0.42	0.42	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	50.15	13.78	64.48	0.73	5.51	11.21	1.29	1.47	1.29	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	45.44	12.33	63.41	2.82	1.41	26.07	0.00	0.35	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	50.89	21.06	47.82	1.75	3.07	16.23	0.88	0.88	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	57.19	101.31	62.25	3.14	3.84	34.35	2.62	1.74	2.27	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	52.41	76.19	37.91	4.83	3.35	28.99	2.23	0.74	0.74	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	64.45	142.48	55.61	2.16	6.04	39.45	1.51	0.43	1.29	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	44.22	16.38	52.41	1.64	5.73	7.78	3.69	0.41	1.23	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	46.13	17.38	45.90	1.39	2.55	22.02	0.23	0.23	0.70	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	47.79	18.10	45.93	0.93	3.71	16.70	0.93	0.70	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	76.07	52.75	12.64	1.96	3.27	1.96	0.65	0.65	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	89.63	44.12	19.87	1.85	6.47	5.77	1.39	0.00	0.00	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	85.78	45.71	14.73	1.30	7.36	4.77	0.43	0.00	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	116.48	48.43	18.69	2.96	3.11	4.52	0.93	0.31	0.00	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	106.01	40.52	19.56	2.62	7.16	1.75	0.35	0.17	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	73.13	31.44	15.83	3.12	4.91	2.90	0.67	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	79.36	59.20	20.67	1.79	6.12	7.14	0.51	0.26	0.26	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	82.78	46.77	20.64	2.85	3.95	5.93	0.66	0.00	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	81.48	55.79	17.48	2.32	8.00	3.79	0.42	0.21	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	126.00	50.81	24.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	147.80	36.61	27.12	4.07	1.36	1.36	2.03	0.00	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	142.91	39.35	25.89	1.04	3.11	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	163.11	53.84	32.52	5.86	7.46	5.33	0.00	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	192.45	42.35	35.38	5.90	2.68	0.54	0.54	0.00	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	126.35	43.52	24.57	4.21	1.40	1.40	0.00	0.70	0.70	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	135.69	48.63	26.67	2.35	3.14	0.78	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	177.97	56.69	31.64	1.32	3.95	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	55.07	21.37	32.05	1.64	25.48	5.75	0.00	0.00	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	46.43	12.33	26.12	2.18	14.51	8.71	0.73	0.00	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	60.58	14.14	29.28	2.02	14.14	7.07	0.00	0.00	1.51	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	149.10	87.28	56.16	20.61	6.06	0.81	1.21	0.81	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	103.87	56.33	45.14	15.98	2.00	1.60	0.80	1.60	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	39.16	21.09	4.02	1.00	12.05	2.01	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	65.73	28.65	10.67	4.49	7.87	8.99	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	121.37	89.05	29.31	16.53	18.04	0.75	0.00	0.00	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	136.87	97.41	27.51	16.01	27.51	2.93	1.58	0.00	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	85.69	33.56	14.64	6.78	31.06	2.14	0.00	0.00	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	54.50	38.58	16.53	10.41	34.90	0.61	1.84	0.61	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	78.69	43.31	23.79	11.28	46.05	1.83	2.74	0.91	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	134.51	59.21	27.06	13.02	1.02	0.26	0.77	0.26	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	156.32	65.13	28.30	17.29	0.67	0.90	0.45	0.00	0.22	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	150.05	51.17	37.08	14.37	1.44	0.00	0.57	0.00	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	130.38	44.09	13.27	6.16	6.16	0.95	1.90	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	149.59	60.40	16.15	8.43	10.53	0.00	0.70	0.00	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	141.74	49.44	13.18	3.30	9.89	0.00	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	99.43	66.77	35.41	31.22	3.32	2.89	2.60	0.43	0.72	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	139.64	77.95	39.99	40.84	4.07	1.53	1.69	0.68	0.85	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	116.23	83.99	36.75	43.04	4.67	1.13	1.13	0.64	0.64	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	95.04	52.90	19.73	9.41	6.72	0.90	0.90	0.00	1.79	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	87.70	55.90	19.57	15.37	2.10	0.35	0.70	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	91.96	62.04	18.48	10.56	8.36	0.44	0.44	0.44	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	96.98	59.03	33.73	15.18	3.79	0.42	2.95	1.26	0.00	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	128.19	86.22	42.18	23.27	3.95	0.83	2.08	0.62	0.62	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	103.58	79.19	34.08	20.38	3.34	1.67	1.34	1.00	1.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	132.70	62.00	9.25	3.81	12.24	0.00	0.54	0.27	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	120.05	45.56	12.33	5.36	16.08	0.00	0.00	0.54	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	98.63	44.83	16.14	3.59	8.97	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	149.46	109.40	43.20	29.11	4.82	2.23	0.93	0.37	0.74	1.67
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	139.50	86.65	43.11	25.13	3.90	0.87	0.43	0.22	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	141.64	84.90	44.55	30.68	2.31	1.89	0.84	0.21	0.21	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	111.74	83.93	13.65	11.12	14.66	1.01	0.51	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	133.87	89.68	21.66	13.00	24.70	0.00	0.87	0.43	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	109.83	81.06	14.38	4.79	23.10	1.31	1.31	0.44	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	182.11	100.95	23.75	24.25	2.97	0.00	1.98	0.49	0.49	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	179.10	87.70	23.08	12.92	0.00	0.00	0.00	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	168.89	89.33	18.15	19.54	1.40	0.00	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	186.37	93.88	21.60	14.68	6.09	0.83	0.55	0.83	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	196.56	110.67	23.56	10.80	2.21	0.49	1.96	0.25	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	163.24	101.64	21.56	20.02	0.00	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	171.18	93.11	17.55	16.83	0.72	0.00	0.36	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	196.67	95.56	19.39	15.23	2.77	0.00	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	55.66	33.39	12.77	8.51	44.20	1.31	0.00	0.00	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	43.93	24.40	14.27	13.14	34.92	1.50	1.88	0.75	1.13	0.75
CD8+ T Cells, donor3	11383-118B6	65.90	29.04	13.38	7.57	45.45	1.26	0.50	0.76	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	80.98	111.03	14.91	17.20	10.09	0.92	3.21	1.38	0.69	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	72.85	113.83	9.83	11.02	6.95	0.24	2.16	0.00	0.24	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	85.91	108.07	10.12	14.77	7.93	1.09	2.19	0.82	0.27	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	85.86	136.60	11.71	9.61	9.61	0.60	2.70	0.60	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	55.44	95.03	13.44	11.52	6.72	0.96	0.48	0.48	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	83.68	112.56	13.42	14.33	12.96	0.91	1.14	0.91	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	74.53	129.07	10.86	18.03	10.43	0.65	1.09	0.87	0.22	1.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	68.70	140.81	8.69	15.27	7.63	1.32	1.84	0.26	0.79	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	72.47	122.65	9.62	18.76	8.91	1.17	3.75	1.17	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	72.75	138.56	14.19	13.89	7.55	0.60	3.02	0.60	0.60	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	68.85	110.10	12.49	16.85	7.84	0.58	2.03	0.29	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	62.88	96.98	10.12	16.52	7.46	0.53	1.07	0.53	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	39.40	78.80	14.88	8.32	5.25	3.06	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	40.99	70.59	10.02	7.29	7.74	3.64	0.46	0.00	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	26.85	79.06	19.39	8.20	4.48	3.73	0.75	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	85.72	118.13	15.49	16.21	9.36	1.08	1.80	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	83.15	118.54	12.66	19.85	12.95	2.59	2.01	0.86	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	71.65	90.98	16.73	16.03	8.25	1.89	1.89	0.94	1.18	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	70.35	112.50	11.41	13.94	8.87	0.63	2.85	0.32	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	85.50	127.33	12.61	19.38	11.69	0.62	1.85	0.62	0.00	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	72.13	112.52	8.66	14.11	11.86	0.96	2.24	0.64	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	65.40	103.65	11.09	11.86	6.50	1.53	1.91	0.00	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	60.69	100.50	11.03	12.61	5.52	0.79	1.97	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	56.73	117.24	9.08	11.35	6.81	1.51	3.03	0.76	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	69.05	104.38	23.29	18.47	12.04	7.23	0.00	0.00	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	69.24	88.13	30.77	20.98	22.38	9.79	1.40	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	57.10	99.17	33.06	16.03	13.02	8.01	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	47.52	71.28	3.66	5.48	0.00	1.83	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	42.49	51.88	7.41	12.35	0.49	0.00	1.48	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	48.41	43.78	5.16	6.52	0.95	0.63	0.32	0.00	0.00	0.32
Chondrocyte - de diff, donor1	11261-116G1	54.77	61.71	4.16	1.73	3.47	0.00	1.39	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	42.65	31.98	1.42	2.13	0.71	0.00	0.00	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	47.90	33.00	5.46	3.53	1.25	0.00	0.91	0.23	0.11	0.57
Chondrocyte - re diff, donor2	11339-117F7	54.61	30.44	0.90	3.58	3.58	0.90	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	30.73	29.52	2.43	2.83	0.40	0.00	0.40	0.40	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	65.41	52.33	12.05	17.44	3.10	1.15	0.46	0.23	1.03	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	53.87	35.91	6.63	11.54	0.64	0.00	1.07	0.86	1.50	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	60.36	39.38	8.23	14.43	1.59	0.53	0.97	0.18	0.27	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	71.43	23.29	11.83	10.91	49.98	2.57	0.92	0.46	0.09	0.37
Corneal Epithelial Cells, donor1	11526-119I5	28.32	49.84	5.71	6.59	2.20	0.00	0.00	0.00	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	32.99	39.82	4.55	4.55	1.14	0.00	1.14	0.00	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	54.45	64.93	5.37	7.67	4.86	0.26	1.53	0.51	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	52.34	18.99	23.11	4.29	0.17	0.17	0.00	0.17	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	48.57	14.19	21.45	3.15	0.63	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	34.51	10.35	0.00	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	55.83	20.73	17.93	2.92	0.11	0.97	0.65	0.32	0.11	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	69.01	17.08	25.96	4.10	3.07	1.02	0.00	0.00	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	49.62	16.32	24.81	3.26	2.61	1.96	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	65.82	14.03	36.78	7.26	2.42	1.45	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	55.03	31.69	12.34	13.17	0.83	1.50	0.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	32.27	24.64	13.50	8.80	0.00	1.76	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	36.76	30.26	14.42	9.62	1.98	2.83	1.70	0.28	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	32.24	24.77	6.68	7.86	1.18	1.18	0.00	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	32.58	15.71	5.24	6.69	0.29	3.20	0.00	0.00	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	48.47	35.76	14.82	11.53	1.65	2.59	1.41	0.24	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	67.84	41.20	9.47	13.85	1.75	2.28	1.23	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	54.53	34.58	16.18	16.85	0.22	9.09	0.44	0.22	1.55	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	46.86	33.47	14.30	14.30	0.61	12.17	0.61	0.61	1.22	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	44.82	40.88	20.02	14.38	0.85	11.84	0.00	0.56	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	29.71	18.42	13.07	8.91	0.89	1.19	0.89	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	23.95	26.03	5.73	3.64	0.52	1.56	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	24.10	16.87	15.17	8.22	0.57	3.26	0.57	0.00	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	89.63	59.62	16.00	11.20	1.20	4.00	0.00	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	30.92	18.87	5.77	5.77	1.05	3.14	1.05	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	90.95	65.35	17.77	21.49	1.24	4.60	1.49	0.12	1.12	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	37.37	32.59	16.95	16.95	0.87	4.35	0.43	0.65	0.65	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	57.03	38.47	16.85	21.62	2.20	4.27	0.24	0.00	0.12	0.24
Endothelial Cells - Vein, donor1	11267-116G7	28.44	14.79	12.51	10.24	1.14	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	28.64	27.24	11.18	9.08	0.70	0.70	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	48.52	26.69	12.09	13.97	0.63	1.88	0.63	0.00	0.16	0.31
Eosinophils, donor1	12244-129H3	45.74	76.23	0.00	15.25	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	57.76	24.75	90.76	14.85	16.50	36.31	0.00	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	46.37	24.97	53.50	10.70	39.24	57.07	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	27.12	45.93	3.42	1.95	0.98	0.00	0.00	0.00	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	39.52	6.24	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	65.08	0.00	0.00	0.00	0.00	16.27	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	35.30	22.99	8.21	4.11	0.00	1.23	0.00	0.41	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.48	11.82	2.08	1.42	0.22	0.11	0.33	0.33	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	29.68	27.84	7.58	6.72	0.76	0.43	1.52	0.54	0.00	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	52.27	39.17	6.91	5.34	2.55	0.61	0.49	0.36	0.12	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	37.12	31.66	6.69	3.68	0.96	2.46	0.00	0.00	0.27	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	34.91	32.38	4.64	3.80	0.63	0.53	0.95	0.53	0.53	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	54.81	45.06	5.80	5.01	1.84	1.32	0.79	0.79	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	45.51	37.54	7.97	10.63	2.66	1.00	1.33	0.33	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	40.37	34.48	4.08	6.80	1.81	0.45	0.45	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	31.83	32.59	3.03	6.82	0.00	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	25.55	19.71	4.89	3.31	0.79	1.26	1.10	0.32	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	58.80	54.86	9.70	4.24	1.82	2.12	0.00	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	57.23	48.48	10.28	9.64	2.41	2.16	1.14	0.63	0.13	0.13
Fibroblast - Cardiac, donor6	11460-119B2	60.64	69.88	8.34	12.73	1.06	1.21	1.36	0.15	0.45	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	48.91	45.02	6.70	6.43	1.07	0.54	0.27	0.00	1.47	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	54.36	45.73	4.75	4.75	0.43	0.43	1.29	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	64.45	58.59	5.86	16.11	1.46	0.00	0.00	0.00	0.00	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	66.19	47.97	6.69	6.46	1.38	0.23	0.23	0.00	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	59.53	78.19	7.46	12.72	0.85	0.85	0.51	0.17	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	38.74	29.35	3.99	1.64	0.70	0.00	0.70	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	41.04	41.98	7.55	4.72	2.83	0.47	0.47	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	60.44	53.55	4.59	2.30	1.21	0.12	0.97	0.85	0.12	0.60
Fibroblast - Dermal, donor4	11450-119A1	81.96	48.72	10.40	14.70	4.18	0.23	2.71	0.79	0.68	0.34
Fibroblast - Dermal, donor5	11454-119A5	103.97	68.04	11.17	14.31	4.19	0.70	3.49	1.05	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	102.65	84.46	15.76	19.17	6.98	0.32	1.79	1.62	0.49	0.16
Fibroblast - Gingival, donor1	11237-116D4	55.81	31.03	6.66	3.54	0.42	0.00	0.42	0.00	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	49.26	27.25	3.93	6.29	1.05	0.00	0.79	0.00	0.00	0.52
Fibroblast - Gingival, donor2	11318-117D4	86.85	44.67	12.65	23.98	4.09	0.79	1.58	0.92	0.66	0.53
Fibroblast - Gingival, donor3	11394-118C8	58.40	33.07	14.41	3.58	0.58	1.06	0.58	0.29	0.00	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	37.40	11.43	9.35	13.51	0.00	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	32.77	20.44	7.40	6.70	1.41	0.18	1.06	0.18	0.00	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	71.56	58.62	12.78	15.12	3.12	0.16	1.09	0.16	0.00	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	53.01	32.86	11.49	10.55	2.70	0.00	1.08	0.27	0.00	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.17	12.70	7.41	7.06	0.35	1.06	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	54.55	37.58	8.34	9.80	2.49	0.44	0.29	0.00	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	68.99	42.68	9.41	7.23	1.50	0.27	0.95	0.68	0.00	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	76.24	58.69	14.70	14.15	4.83	0.77	0.99	0.22	0.00	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	48.72	28.17	5.72	12.18	0.29	0.73	0.29	0.15	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	31.27	32.62	9.52	9.52	1.36	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	52.23	56.70	5.97	13.43	1.49	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	72.39	52.97	14.56	20.05	1.90	0.42	2.11	0.42	0.00	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	53.31	93.30	15.83	10.00	3.33	0.00	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	43.36	4.20	5.59	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	14.83	19.59	3.92	3.64	0.28	0.28	0.28	0.84	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	102.71	122.60	8.12	13.40	4.47	1.62	0.00	0.41	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	39.94	39.94	3.99	7.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	17.87	0.00	0.00	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	89.03	43.45	10.86	17.65	2.13	0.00	0.97	0.58	0.78	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	94.80	57.49	14.56	22.90	4.25	0.46	2.88	0.46	0.30	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	69.15	39.47	9.79	6.12	0.61	0.61	0.61	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	37.78	23.28	6.49	6.49	2.29	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	38.61	27.27	7.02	4.86	0.81	0.00	2.16	0.27	0.00	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	38.85	17.28	10.44	5.45	1.16	0.35	0.58	0.00	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	62.23	62.12	8.51	12.16	4.09	0.33	0.66	0.44	0.00	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	64.21	59.13	13.00	11.18	3.45	1.02	0.61	0.61	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	64.15	42.77	8.69	10.02	1.34	1.34	2.00	0.00	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	40.33	39.14	5.93	6.72	0.79	0.00	1.19	1.19	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	88.90	63.30	7.14	8.33	4.76	0.79	1.59	0.60	0.20	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	35.35	26.29	3.37	3.37	0.71	0.00	0.00	0.18	0.53	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	44.54	56.96	4.14	2.96	0.79	0.39	0.59	0.00	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	77.02	60.47	7.52	3.91	6.32	0.30	0.90	0.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	56.57	59.91	4.21	3.13	0.86	0.11	0.65	0.11	0.22	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	72.89	49.35	6.07	3.29	2.53	0.00	0.25	0.76	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	32.49	32.65	3.12	3.28	0.16	0.33	0.16	0.16	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	60.75	60.55	9.62	7.62	3.81	1.00	0.20	0.20	0.40	0.40
Fibroblast - skin normal, donor2	11561-120D4	48.02	46.11	4.72	3.62	1.61	0.50	0.90	0.30	0.10	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	105.48	89.76	8.46	6.35	3.63	0.30	1.21	1.21	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	49.87	43.91	4.47	3.65	0.58	0.17	0.41	0.25	0.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	45.99	65.47	4.10	5.98	0.68	0.17	1.37	0.34	0.85	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	67.33	31.86	3.28	2.96	6.24	0.66	0.66	0.66	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	51.88	34.94	4.79	5.11	2.98	0.43	0.64	0.11	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	54.99	34.58	6.58	8.60	2.70	0.00	0.67	0.17	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	27.91	18.19	2.82	1.41	0.31	0.00	1.57	0.94	0.00	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	243.76	110.80	44.32	22.16	0.00	0.00	66.48	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	41.83	27.02	7.84	8.72	2.61	0.00	0.00	0.00	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	52.87	41.78	10.57	6.76	1.04	0.52	0.17	0.00	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	55.43	39.30	3.38	6.51	0.78	0.52	0.26	0.78	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	45.48	38.58	5.37	4.34	1.28	0.26	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	94.16	58.18	17.61	64.31	11.48	0.77	1.53	0.77	0.77	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	126.34	65.08	23.61	56.79	8.29	1.91	2.55	0.00	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	123.52	60.19	38.80	47.92	6.28	2.85	3.71	2.85	2.00	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	62.32	15.17	24.27	28.68	3.03	2.76	0.83	0.55	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	55.25	20.78	20.78	24.43	8.45	0.46	0.91	0.00	0.23	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	88.37	49.53	38.24	55.08	3.76	2.97	1.39	1.19	1.59	2.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	57.10	16.12	24.05	26.43	1.85	1.06	0.53	0.26	0.53	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	53.81	19.24	28.70	31.96	9.13	1.96	0.98	0.33	0.65	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	114.54	69.87	34.05	41.57	3.98	5.31	2.65	1.77	1.33	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	104.15	47.06	20.49	50.45	3.11	0.28	3.25	1.27	0.14	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	78.32	46.55	12.56	39.65	5.42	0.25	2.09	0.99	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	86.50	54.53	19.88	48.62	5.91	1.34	4.30	1.07	0.00	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	76.81	47.08	11.40	23.66	3.47	0.99	2.23	0.87	0.00	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	93.58	55.79	14.40	30.18	3.46	0.69	3.60	0.83	0.00	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	81.52	54.08	11.99	31.31	2.64	1.02	4.07	0.61	0.00	1.63
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	59.55	42.90	8.90	25.78	1.60	1.14	1.14	0.46	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	68.64	52.07	10.96	33.13	2.74	0.37	3.61	0.62	0.00	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	54.86	43.28	13.33	40.00	1.97	1.31	1.09	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	54.37	37.82	7.68	18.32	4.43	2.36	1.77	0.59	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	78.37	42.28	13.03	22.89	5.56	1.59	2.86	0.48	0.00	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	62.33	49.38	10.05	38.20	4.92	3.13	1.34	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	74.60	44.56	11.69	20.77	5.44	1.41	3.23	0.40	0.00	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	85.67	35.79	15.27	20.53	4.58	1.02	3.05	0.51	0.17	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	65.26	45.75	11.70	25.89	7.36	1.42	0.89	0.53	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	56.09	36.84	9.47	12.90	4.06	1.56	0.00	0.10	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	51.75	36.89	6.32	9.73	3.42	1.71	0.17	0.17	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	77.68	37.84	12.73	14.72	4.54	1.00	1.88	0.55	0.11	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	64.56	42.60	12.90	19.63	5.66	1.00	0.42	0.17	0.08	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	60.44	37.77	13.07	19.19	7.55	1.43	0.61	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	61.27	34.25	9.28	20.01	4.95	1.65	1.44	0.62	0.00	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	77.48	31.71	14.41	18.79	6.80	1.50	1.04	0.58	0.00	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	60.20	39.52	11.17	17.51	4.17	0.67	1.50	0.17	0.00	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	58.41	31.96	9.48	16.97	4.85	1.76	0.66	0.44	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	79.21	46.25	10.09	15.25	6.03	1.23	1.72	1.11	0.00	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	48.79	31.93	12.32	18.48	4.38	1.95	1.46	0.16	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	60.29	42.33	8.34	8.66	7.38	1.60	0.64	0.64	0.00	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	61.97	31.17	12.03	13.46	5.12	1.99	1.61	1.33	0.00	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	56.15	36.86	7.12	12.50	2.85	1.58	1.11	0.16	0.00	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	53.22	37.40	7.30	14.60	4.87	2.74	2.43	0.91	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	61.26	27.60	8.26	12.13	4.91	1.99	1.15	0.42	0.10	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	45.45	45.89	6.81	9.44	5.05	2.20	1.10	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	51.62	33.39	4.77	10.10	4.77	2.24	1.40	0.00	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	54.53	31.11	8.06	12.13	2.31	2.13	1.02	0.46	0.00	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	51.88	48.67	8.56	11.23	3.74	1.07	0.80	0.80	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	58.75	45.75	8.11	15.76	2.60	2.45	0.61	0.77	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	54.41	39.64	6.99	13.08	3.63	2.20	1.68	0.39	0.13	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	46.08	46.08	6.51	11.39	2.44	2.71	0.81	1.36	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	50.33	32.81	6.45	11.43	2.03	2.21	1.11	0.37	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	43.42	31.14	7.46	10.31	2.41	1.75	0.88	0.66	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	41.65	29.75	6.94	8.93	1.98	2.98	0.00	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	48.41	28.10	5.41	9.76	1.06	0.79	0.66	0.13	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	49.43	29.05	7.26	9.08	1.01	1.21	0.20	0.81	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	33.04	39.39	10.17	5.85	2.54	2.80	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	137.35	73.25	21.90	56.13	5.18	0.80	3.18	0.40	0.00	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	101.38	57.16	19.88	51.15	4.16	0.77	2.93	1.39	0.46	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	156.92	59.12	31.10	65.26	4.09	1.02	4.71	1.64	0.00	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	133.00	56.01	27.54	52.89	5.01	0.31	1.88	0.31	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	135.63	60.47	20.06	51.99	8.76	2.26	1.70	0.85	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	96.39	40.12	24.44	40.59	5.07	0.00	0.92	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	76.72	44.55	37.12	59.40	9.90	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	102.50	57.63	29.40	68.08	7.74	0.00	2.71	1.55	0.39	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	118.73	70.60	19.25	51.34	6.42	1.60	1.60	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	74.77	39.99	27.82	69.55	12.17	1.74	3.48	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	95.04	39.71	19.20	58.91	10.09	0.65	2.28	0.00	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	109.54	40.36	23.88	42.83	7.41	0.41	3.29	0.82	0.82	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	73.31	33.32	23.33	46.65	13.33	10.00	0.00	6.66	3.33	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	81.66	33.28	15.38	35.52	8.39	0.28	1.68	1.12	0.00	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	81.38	40.86	17.32	47.39	10.79	1.31	3.60	1.63	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	57.88	26.00	15.94	36.07	14.26	2.52	1.68	2.52	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	78.25	44.85	12.09	46.44	7.95	0.95	1.59	0.64	1.27	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	78.12	40.08	13.25	37.36	11.55	0.68	2.04	0.68	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	71.00	33.41	18.79	48.03	2.09	2.09	0.00	0.00	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	76.74	50.40	13.17	44.67	8.02	0.00	5.15	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	66.00	29.89	11.25	32.56	6.22	0.59	2.07	0.30	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	50.82	28.80	15.25	38.97	3.39	0.00	0.00	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	69.17	36.86	17.81	40.18	7.87	0.41	2.90	0.83	0.00	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	67.20	38.43	14.27	42.11	12.43	0.46	2.07	1.15	0.00	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	26.34	5.27	47.42	0.00	0.00	0.00	0.00	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	76.88	31.14	14.61	41.13	5.38	0.00	0.77	0.38	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	54.76	29.66	10.76	27.38	3.59	0.33	2.61	0.65	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	32.77	23.41	14.71	31.44	2.68	1.34	0.67	1.34	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	68.96	41.99	11.94	30.05	5.01	0.39	1.16	0.77	0.77	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	97.57	72.23	16.43	48.61	5.14	2.05	2.40	1.37	0.34	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	27.33	7.45	42.24	4.97	0.00	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	49.07	33.97	6.61	28.78	1.89	0.00	1.89	1.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.90	38.02	9.05	33.80	2.41	0.60	1.81	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.90	34.59	11.70	33.06	3.05	1.53	2.03	0.51	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	62.62	47.06	11.57	22.73	5.98	0.80	1.60	0.40	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	61.18	32.56	5.43	24.17	3.95	0.49	0.49	0.00	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	63.74	48.40	7.08	37.77	4.72	3.54	0.00	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	47.84	43.76	8.75	30.92	3.50	0.58	0.58	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	51.35	40.38	7.46	25.46	4.83	0.88	2.19	0.44	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	46.62	30.52	14.41	22.04	1.70	0.00	4.24	0.85	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	52.53	26.86	14.92	20.89	6.57	2.39	1.19	0.60	0.00	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.36	22.32	4.37	23.78	3.40	0.97	1.46	0.00	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	42.23	34.24	3.42	2.28	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	31.19	17.46	4.99	4.16	0.42	0.83	0.42	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	64.09	26.99	5.62	6.75	2.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	31.08	53.92	3.17	4.44	1.27	0.63	0.32	0.95	0.32	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	22.14	40.10	2.51	1.25	0.84	0.00	2.09	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	67.77	78.91	15.20	12.07	6.85	0.93	3.83	0.81	0.00	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	73.09	100.61	14.69	14.69	8.44	0.68	2.19	0.68	0.17	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	72.12	100.33	14.33	12.97	8.42	0.91	2.73	0.91	0.00	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	78.37	90.84	13.77	14.21	6.67	0.77	2.84	0.66	0.11	1.75
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	67.48	91.12	14.83	15.04	6.88	0.64	1.72	0.00	0.00	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	72.12	91.93	11.84	13.78	7.75	0.43	3.01	0.22	0.00	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	62.52	65.88	14.45	14.45	6.97	1.99	1.62	0.50	0.12	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	62.27	74.45	11.84	12.69	4.63	1.03	2.57	0.34	0.34	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	62.47	68.56	11.85	14.10	7.05	0.64	1.28	0.64	0.32	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	44.21	31.34	22.94	19.03	1.68	8.95	1.68	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	37.22	33.76	6.49	18.18	2.16	0.87	0.43	0.43	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	58.16	47.59	13.22	13.22	0.00	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	45.15	42.33	4.94	11.64	1.06	0.35	0.00	0.00	0.00	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	48.68	45.77	7.27	9.44	0.00	0.00	0.00	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	45.81	59.97	6.12	17.13	5.42	0.87	2.62	0.17	0.00	1.05
Hepatocyte, donor1	11523-119I2	30.27	73.85	14.53	8.47	1.21	2.42	7.26	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	71.10	117.43	21.55	10.77	2.15	6.46	3.23	3.23	0.00	2.15
Hepatocyte, donor3	11684-122I1	56.45	73.01	11.04	11.04	2.45	5.52	0.61	1.23	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	113.57	41.12	38.51	37.20	22.84	0.65	5.22	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	96.83	76.20	14.51	44.92	3.50	3.85	1.40	0.87	1.05	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	41.57	31.56	4.25	5.76	1.23	0.27	0.27	0.27	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	85.97	47.76	28.66	12.74	3.18	9.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	46.73	6.68	20.03	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	81.25	0.00	27.08	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	47.07	74.76	12.46	27.69	5.54	8.31	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	57.56	7.51	15.02	0.00	7.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	106.81	0.00	47.47	11.87	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	74.32	17.94	20.50	2.56	0.00	0.00	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	73.13	9.14	22.85	0.00	0.00	0.00	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	64.97	81.22	16.24	17.87	4.87	6.50	3.25	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	85.03	5.00	16.67	5.00	5.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	61.72	7.26	21.78	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	58.23	67.50	14.56	25.15	5.29	5.29	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	49.89	76.50	7.76	16.63	3.33	0.00	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	62.86	0.00	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	69.91	71.80	11.97	15.12	7.56	2.52	1.89	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	71.14	69.60	9.28	21.65	0.00	0.00	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	73.17	0.00	58.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	60.08	62.67	15.50	15.50	5.81	2.58	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	59.57	56.35	4.83	24.15	3.22	4.83	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	83.64	11.95	47.79	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	54.60	67.63	19.56	8.15	2.44	4.07	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	41.14	58.35	9.66	13.85	4.20	7.14	0.42	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	43.12	0.00	0.00	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	61.08	68.31	8.04	16.07	0.80	3.21	1.61	0.80	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	42.47	39.70	9.23	16.62	5.54	2.77	1.85	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	60.32	0.00	30.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	57.12	52.40	7.08	17.94	6.14	2.36	1.42	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	36.28	39.91	8.16	8.16	1.81	0.91	0.91	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74	0.00	73.71	0.00	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	64.57	57.03	20.45	19.37	2.15	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	43.20	72.42	16.52	8.89	6.35	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	65.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	34.43	56.12	10.84	15.94	2.55	0.64	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	34.63	72.91	7.29	14.58	3.65	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	94.83	0.00	31.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	43.56	47.13	13.57	12.85	3.57	2.86	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	49.77	53.09	19.91	19.91	0.00	9.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	125.09	0.00	62.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	63.58	58.03	9.26	12.04	3.70	0.31	1.85	0.31	0.00	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	50.92	52.68	7.02	12.29	5.27	3.51	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	50.29	50.29	3.14	12.57	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	59.11	59.11	12.52	16.69	4.17	2.09	2.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	50.90	39.84	4.43	26.56	2.21	4.43	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	68.08	12.97	22.69	9.73	6.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	42.72	42.72	13.08	16.57	3.49	1.74	2.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	29.25	53.99	22.50	13.50	6.75	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	45.30	17.42	13.94	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	39.47	27.74	5.33	18.14	1.07	10.67	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	54.03	8.31	19.40	1.39	5.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	39.89	76.94	5.70	5.70	11.40	5.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	59.83	54.31	11.97	10.12	2.76	3.68	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	51.43	6.05	9.08	6.05	12.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	49.67	0.00	12.42	12.42	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	30.66	45.47	16.92	17.98	4.23	4.23	2.11	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	36.47	39.41	2.37	0.49	0.65	0.08	0.24	0.33	0.00	0.08
Keratinocyte - epidermal, donor2	11349-117G8	15.23	24.60	1.76	0.59	0.59	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	77.24	64.65	7.67	7.86	1.70	0.19	1.33	1.61	0.09	0.57
Keratinocyte - oral, donor1	11251-116E9	80.60	97.40	5.34	9.31	1.93	0.23	1.59	0.68	0.00	0.45
Keratocytes, donor1	11527-119I6	75.64	37.48	9.97	6.53	1.72	1.03	0.00	0.34	0.00	0.69
Keratocytes, donor2	11607-120I5	56.25	43.36	4.69	14.06	3.52	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	70.54	42.88	11.26	2.96	0.99	0.99	1.58	0.20	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	43.96	26.37	30.77	6.59	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	51.78	34.52	4.31	10.79	2.16	0.00	1.08	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	49.71	33.33	13.61	14.76	3.00	1.38	0.00	0.23	0.00	0.23
Lens Epithelial Cells, donor3	11690-122I7	34.91	25.43	4.24	6.05	0.50	0.40	0.20	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	52.17	55.97	14.82	9.84	1.78	2.25	0.95	0.47	0.12	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	39.63	42.42	12.00	3.35	1.67	3.35	1.40	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	54.94	52.42	16.06	10.55	1.57	2.83	2.52	0.16	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	40.33	33.34	9.68	6.45	2.15	3.76	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	35.30	38.14	14.50	7.25	2.21	2.84	0.63	0.63	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	42.26	41.40	12.61	9.92	2.05	2.59	1.94	0.97	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	52.53	40.63	13.13	6.16	0.00	3.69	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	32.61	28.32	12.39	5.81	1.01	3.03	0.51	0.51	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	42.93	41.94	12.67	10.70	1.27	2.96	0.70	0.99	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	39.95	36.39	13.45	6.33	0.79	2.37	1.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	51.19	45.95	16.29	6.79	0.97	2.71	0.78	0.39	0.00	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	23.33	34.25	9.26	6.67	0.56	2.78	0.37	0.56	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	39.72	41.46	13.24	9.41	1.39	2.79	1.05	0.35	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	38.40	37.93	11.69	6.92	2.62	2.86	0.72	0.24	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	44.23	39.28	11.13	9.48	1.37	2.47	0.82	0.96	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	55.12	46.19	12.01	5.54	2.77	3.70	1.54	0.31	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	31.49	35.23	11.22	3.74	1.87	2.81	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	45.38	49.96	10.98	7.87	2.74	2.93	2.01	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	44.10	48.05	16.13	7.90	1.97	3.95	0.99	0.66	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	35.44	35.73	8.20	5.56	1.17	2.64	1.17	0.00	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	41.07	41.32	13.69	9.46	1.74	0.75	0.75	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	32.49	33.46	8.24	6.79	1.45	2.91	0.48	0.00	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	45.51	41.74	13.20	7.00	1.35	3.50	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	42.69	41.78	10.75	10.14	1.51	2.12	2.42	0.15	0.15	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	40.95	42.51	9.85	5.70	2.07	2.59	0.00	0.52	0.00	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	49.83	43.97	18.85	6.49	0.84	2.72	0.42	1.05	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	37.89	40.00	11.13	8.42	0.75	2.41	1.20	0.00	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	38.52	52.28	19.95	5.50	2.06	5.50	0.69	0.00	0.00	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	44.78	36.50	12.04	5.64	1.88	3.01	0.94	0.75	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	34.99	37.22	10.28	7.85	1.06	2.01	1.06	0.64	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	48.94	50.40	11.63	6.78	2.42	4.85	1.45	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	40.36	41.02	13.89	9.26	0.66	3.64	0.33	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	33.57	39.03	10.90	7.93	0.50	1.61	0.99	0.50	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	44.05	47.76	18.14	7.03	1.48	4.81	1.85	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	45.22	40.77	14.08	5.93	0.74	3.21	0.25	0.00	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	33.41	38.09	10.45	6.87	1.10	2.06	1.24	0.41	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	40.85	52.11	12.54	10.29	2.25	0.96	0.64	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	53.56	52.04	16.74	10.35	0.91	1.83	0.91	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	45.77	46.19	15.12	8.82	2.10	2.38	0.98	0.70	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	49.42	38.40	11.73	6.76	2.49	3.20	0.71	0.36	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	30.54	32.96	9.70	6.30	1.45	3.39	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	29.57	31.28	10.11	6.85	1.24	1.87	1.24	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	48.70	50.13	10.74	9.31	1.79	2.86	0.36	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	39.20	45.41	16.66	7.84	1.96	0.98	0.65	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	25.19	31.55	8.71	7.30	0.94	1.41	0.94	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	59.90	63.24	19.80	12.87	1.49	2.72	1.49	0.37	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	31.50	33.04	10.76	6.40	1.28	2.56	0.26	0.26	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	40.28	37.89	11.04	7.76	1.19	4.18	0.90	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	52.12	83.84	33.99	52.12	6.80	2.27	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	59.07	54.47	22.25	46.03	6.14	3.84	3.07	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	44.53	60.86	25.24	31.92	10.39	0.74	0.00	1.48	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	69.82	88.86	25.39	52.04	7.19	2.96	3.81	0.42	0.85	4.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	43.61	62.60	20.40	39.39	6.33	1.41	1.41	0.70	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	42.03	56.97	21.48	30.82	9.34	1.87	0.93	1.87	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	52.56	77.29	18.55	34.52	6.70	3.61	7.21	1.55	0.00	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	60.66	53.53	16.65	44.01	10.71	2.38	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	51.80	73.51	23.30	45.01	6.56	2.49	0.45	0.00	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	66.89	89.57	27.63	41.59	8.72	1.45	4.07	1.74	0.87	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	69.33	73.83	25.66	35.56	9.00	2.70	2.70	1.80	0.00	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	65.30	87.25	21.41	46.61	8.54	1.49	0.81	0.54	0.27	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	76.52	86.27	31.32	54.95	5.65	2.57	3.59	0.51	1.54	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	73.75	77.28	18.70	52.58	10.59	1.76	2.47	0.71	0.35	2.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	35.31	73.29	18.66	39.31	5.33	1.33	2.00	2.67	0.67	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	63.67	109.01	35.66	52.98	10.19	3.06	2.55	0.00	1.53	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	74.97	82.71	29.62	44.02	6.67	2.93	2.93	0.53	0.80	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	82.57	86.35	25.89	55.17	12.28	1.89	3.97	0.94	0.57	2.65
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	55.83	103.08	30.06	47.24	7.36	4.29	5.52	0.00	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	72.57	104.37	31.80	48.11	4.89	4.08	3.26	3.26	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	77.26	100.79	22.91	47.06	9.16	2.50	3.12	2.29	0.00	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	70.07	94.17	29.43	46.80	8.41	1.68	5.61	1.68	0.84	3.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	70.06	77.28	19.58	52.55	5.15	4.12	0.00	2.06	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	77.22	94.64	25.84	39.19	9.00	2.32	5.52	3.48	0.58	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	82.80	85.79	23.32	55.30	6.58	2.39	4.78	1.20	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	74.14	73.58	22.68	38.17	4.43	2.77	2.77	0.00	0.00	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	89.43	107.81	28.63	49.49	4.24	2.12	4.95	2.12	0.35	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	72.28	109.90	29.50	52.74	10.33	1.84	6.27	1.84	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	66.77	81.74	27.63	34.54	8.06	3.45	3.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	77.90	100.93	21.49	36.07	10.36	3.45	3.45	2.30	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	57.75	109.26	17.55	39.63	5.10	1.13	3.96	5.10	0.57	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	70.56	93.53	19.69	41.02	5.74	1.64	2.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	76.82	112.97	20.79	42.93	4.07	3.62	5.42	1.36	0.90	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	58.17	102.69	20.11	43.09	5.75	1.44	5.03	0.00	0.00	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	53.03	98.59	24.65	35.85	5.23	3.73	2.24	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	69.12	107.02	14.49	34.93	10.40	1.11	2.23	2.23	0.00	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	67.20	104.24	21.97	36.18	4.31	1.72	1.72	0.86	0.43	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	70.22	91.62	23.98	38.53	6.85	2.57	3.43	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	62.97	99.62	21.66	42.65	6.00	3.00	6.00	0.67	0.00	3.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	43.44	100.75	19.31	42.23	13.27	3.02	1.81	0.60	0.00	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	59.01	92.43	17.77	40.53	4.98	2.13	2.84	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	62.56	89.37	26.47	50.87	6.19	2.75	3.44	1.03	0.69	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	56.36	90.71	17.71	42.94	8.05	3.76	3.76	0.54	0.00	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	49.16	77.44	18.85	35.69	6.06	2.69	2.02	2.69	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	65.56	90.75	25.19	51.86	5.56	1.85	5.56	1.48	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	55.82	87.22	33.72	34.89	9.30	5.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	47.60	74.04	23.27	57.12	4.23	5.29	2.12	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	62.42	94.04	23.61	50.82	7.60	3.20	4.80	0.80	0.80	3.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	59.60	74.87	18.90	50.88	14.54	4.36	4.36	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	55.96	92.75	42.16	44.46	6.90	2.30	3.07	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	61.66	87.80	30.58	49.33	9.87	2.47	1.48	1.48	0.49	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	42.34	82.80	19.76	35.76	2.82	0.00	0.94	2.82	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	67.38	95.54	27.15	56.82	7.54	6.03	1.01	0.00	0.50	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	79.76	113.11	26.59	51.37	9.46	5.41	2.25	0.90	0.45	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	61.96	99.82	34.42	29.26	5.16	1.72	3.44	1.72	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	61.46	85.95	22.27	47.65	8.91	3.12	3.12	0.89	1.78	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	75.86	119.65	23.46	52.79	13.69	3.91	5.87	2.35	0.39	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	60.70	106.22	32.33	60.70	9.90	3.96	3.96	0.00	1.32	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	88.22	102.75	34.77	63.83	8.30	4.67	2.59	1.56	1.56	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	76.14	121.21	27.57	59.51	11.81	4.81	6.56	0.88	0.00	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	59.82	119.65	28.51	48.64	7.83	2.80	2.80	2.24	1.68	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	77.29	99.81	30.03	57.41	6.62	3.53	0.88	0.88	1.77	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	78.69	118.03	24.30	50.91	7.33	2.70	3.86	0.00	0.77	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	70.38	125.07	29.87	44.56	7.09	4.05	3.04	0.51	1.52	3.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	69.21	109.10	30.28	48.54	7.69	3.84	1.44	0.00	0.48	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	88.65	105.75	33.00	50.49	11.13	3.58	5.17	0.00	0.80	3.18
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	62.59	136.11	28.56	37.06	10.94	4.25	2.43	2.43	0.61	3.65
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	69.86	118.28	21.44	26.28	9.68	3.46	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	90.06	117.42	23.56	53.58	9.12	3.42	6.84	1.52	0.38	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	72.30	117.74	22.72	42.86	9.30	1.55	4.65	2.07	0.52	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	63.49	116.70	16.93	32.65	12.70	3.02	3.63	0.00	1.21	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	87.78	116.94	21.55	46.58	11.41	4.12	5.39	2.22	0.32	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	60.24	155.66	19.72	39.45	12.26	3.73	3.73	0.53	1.07	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	77.58	140.22	18.96	27.01	13.22	1.15	2.87	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	93.59	143.47	13.37	42.68	10.80	4.11	6.69	1.03	0.00	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	77.10	161.28	21.22	29.71	18.39	2.12	4.24	0.00	2.12	3.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	82.29	156.06	21.56	32.35	9.08	3.40	2.84	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	86.53	147.69	22.88	46.18	9.57	3.33	5.82	0.00	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	87.70	200.46	21.14	34.45	11.75	1.57	7.05	5.48	0.00	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	87.68	170.36	16.28	27.56	9.60	0.42	1.67	0.00	1.25	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	88.75	167.73	20.91	36.71	12.08	1.39	8.36	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	77.61	181.31	15.39	29.44	12.71	2.68	5.35	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	86.61	187.66	16.04	28.34	11.76	1.60	4.28	1.60	0.53	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	96.58	195.58	12.12	30.31	10.91	2.02	8.89	2.02	0.81	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	89.02	176.21	20.19	29.37	9.18	1.84	4.59	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	85.35	169.82	12.45	24.90	9.78	1.78	2.67	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	70.66	164.69	11.40	32.48	5.70	1.71	5.70	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	78.99	154.15	16.10	29.14	6.14	1.53	3.83	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	76.06	138.44	13.68	23.53	7.11	0.55	2.74	1.64	0.00	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	87.31	147.00	11.58	29.40	5.79	0.45	4.45	0.45	0.00	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	77.47	133.88	16.12	36.65	9.88	1.04	1.30	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	84.21	139.92	11.94	30.50	3.32	2.65	2.65	0.66	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	60.28	155.90	12.47	33.26	10.39	0.00	2.08	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	64.04	34.64	21.65	7.07	1.14	3.65	0.68	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	44.59	17.43	10.64	3.67	0.55	2.20	0.55	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	51.78	30.28	13.76	7.86	1.31	1.84	0.66	0.13	0.00	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	38.23	41.42	2.12	1.06	0.53	0.53	1.06	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	33.43	24.56	3.17	1.43	0.79	0.16	0.32	0.16	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	50.87	46.00	3.34	2.78	0.69	0.14	0.69	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	85.79	103.53	10.06	2.99	4.09	0.60	0.30	0.40	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	55.01	82.52	8.69	6.37	3.76	0.29	2.90	0.58	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	55.87	38.91	7.73	5.74	0.50	0.00	1.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	140.33	29.83	18.30	4.75	2.03	4.75	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	90.51	36.01	28.66	8.54	0.76	7.35	0.11	0.22	0.22	0.22
Mast cell, donor2	11565-120D8	72.21	48.14	21.10	6.54	21.40	8.92	0.00	0.00	0.00	0.30
Mast cell, donor3	11566-120D9	89.37	35.34	36.92	11.26	27.24	8.33	0.00	0.45	0.00	0.68
Mast cell, donor4	11567-120E1	76.23	38.65	21.63	4.43	18.79	7.62	0.00	0.18	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	87.16	23.51	14.97	3.44	0.33	2.44	0.89	0.55	0.11	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	85.22	44.94	11.09	3.50	0.00	1.17	1.17	0.58	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	94.53	32.58	34.53	12.62	0.80	6.19	0.92	0.11	0.11	0.69
Mast cell, expanded, donor8	11941-126A6	83.18	37.66	31.97	9.87	1.34	4.52	1.17	0.17	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	60.79	36.81	16.82	12.34	1.39	3.08	0.60	0.20	0.30	0.00
Melanocyte - dark, donor2	11582-120F7	48.80	55.37	5.88	7.61	1.38	1.04	0.69	0.35	0.00	1.04
Melanocyte - dark, donor3	11663-122F7	69.98	77.51	8.84	23.76	6.23	7.24	0.58	0.29	0.07	0.36
Melanocyte - light, donor1	11274-116H5	23.27	23.27	7.99	4.70	0.71	2.82	0.24	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	23.20	26.62	4.09	3.41	1.36	4.09	0.00	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	29.49	19.95	5.20	4.34	0.87	9.54	0.00	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	86.53	61.95	8.43	21.24	3.44	6.04	1.67	1.15	0.10	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	44.11	71.54	7.26	17.21	4.03	5.38	1.61	0.27	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	53.57	39.91	5.89	10.98	2.95	7.23	1.61	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	93.04	80.27	14.76	21.21	4.84	1.24	0.25	0.12	0.99	0.12
Meningeal Cells, donor2	11573-120E7	66.90	55.02	9.24	14.52	2.64	0.88	3.52	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	82.32	65.20	9.70	20.70	5.71	0.73	0.73	0.73	0.08	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	52.18	57.03	5.42	7.70	1.14	0.29	0.57	0.00	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.46	19.62	5.74	5.64	0.20	1.51	0.00	0.20	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	21.03	6.57	3.94	0.00	2.63	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	39.24	6.54	2.62	0.00	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	64.58	73.20	8.61	5.74	3.59	0.00	1.44	1.44	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	32.61	18.21	9.74	5.93	1.06	1.27	0.00	0.21	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	32.67	27.65	8.54	4.02	2.01	2.51	0.00	0.00	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	53.18	64.17	5.49	9.67	4.61	0.22	0.44	0.00	0.66	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	45.30	67.94	8.77	24.11	8.04	0.00	2.19	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	45.22	54.63	7.16	10.84	3.07	0.20	1.02	0.20	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	35.32	58.59	3.88	2.77	2.08	0.00	0.69	0.28	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.61	30.85	8.55	3.72	0.37	0.37	0.00	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	42.63	41.45	7.63	5.39	0.26	0.39	1.05	0.26	0.00	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	18.69	27.00	5.04	4.75	0.00	0.30	0.30	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	16.35	2.34	7.01	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	46.11	50.59	4.48	10.25	1.28	0.64	1.28	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	87.90	99.24	7.80	7.80	6.03	0.71	0.00	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	46.28	35.96	10.95	1.56	0.00	1.25	0.63	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	75.47	79.10	4.35	10.89	4.35	0.73	2.90	0.00	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	24.40	4.51	8.49	4.77	0.27	1.33	0.27	0.00	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	16.01	6.01	5.51	4.50	0.00	1.00	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	24.79	8.53	6.36	6.07	0.65	0.22	0.51	0.29	0.22	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	9.45	36.46	5.40	1.35	5.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	44.58	15.52	13.55	4.19	1.48	3.45	0.25	0.25	0.00	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	44.17	9.42	14.43	3.53	1.77	2.65	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	3.46	10.37	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	44.94	19.53	13.64	3.72	0.62	2.79	0.31	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	36.92	13.69	8.92	3.11	0.41	1.24	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	9.26	25.48	4.63	0.00	4.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	52.55	19.77	17.52	4.25	0.50	2.75	0.75	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	31.19	13.03	14.90	4.65	1.40	2.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	49.99	17.68	18.29	2.85	0.20	1.63	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	37.62	10.69	13.07	4.36	1.19	1.98	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	17.10	25.65	8.55	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	47.79	26.55	12.39	0.88	0.00	0.88	0.88	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	55.85	9.50	12.92	5.32	1.14	0.76	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	21.05	3.95	10.53	1.32	0.00	5.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	40.96	18.04	10.19	1.91	1.27	2.33	1.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	19.34	9.21	10.13	1.84	0.00	2.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	32.19	11.92	7.45	0.89	0.89	4.17	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	6.71	18.44	1.68	1.68	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	41.90	17.06	12.80	2.51	0.75	3.51	0.50	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	26.62	8.32	11.17	1.43	1.19	2.38	0.71	0.71	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	23.77	12.72	12.72	0.55	0.55	1.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	29.47	16.12	7.83	1.38	0.46	2.99	0.69	0.00	0.00	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	32.81	11.15	9.89	1.05	0.00	1.68	0.00	0.42	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	32.20	18.75	6.93	0.82	0.41	4.08	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	31.32	19.95	7.72	1.93	0.64	4.72	0.21	0.00	0.21	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	23.12	14.89	9.34	0.44	0.22	2.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	10.32	0.00	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	24.31	19.71	7.01	0.44	1.10	3.07	0.22	0.22	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	14.70	8.62	6.59	1.52	1.52	4.06	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	9.94	6.63	0.00	1.66	8.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	22.83	22.56	7.88	2.17	0.82	4.35	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	22.64	20.88	8.23	0.29	1.18	1.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	23.99	18.54	5.45	1.09	1.09	6.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	33.16	36.52	6.25	0.00	0.00	1.92	0.00	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	36.02	29.62	6.00	2.00	1.20	0.80	0.00	0.40	0.80	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	47.99	5.48	1.37	0.00	2.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	46.05	62.57	5.51	0.00	1.00	1.00	0.50	1.00	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	134.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	32.62	8.15	2.04	0.00	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	45.98	66.56	7.88	2.19	1.75	1.75	0.88	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	24.28	6.62	2.21	1.10	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	24.33	30.74	9.61	1.28	0.00	3.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	56.77	60.99	10.16	0.99	2.98	1.49	0.50	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	19.49	22.27	9.74	2.09	0.70	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	28.73	13.26	4.42	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	40.00	44.10	10.26	0.68	1.03	1.71	0.68	0.34	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	23.19	25.38	7.44	0.44	0.88	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	27.34	23.79	13.14	2.49	0.71	2.84	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	56.39	41.52	7.29	1.40	0.84	1.12	0.56	0.56	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.09	34.50	10.39	2.08	0.42	0.42	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.65	12.82	12.82	1.17	1.17	2.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	24.74	29.26	7.84	1.21	1.81	1.51	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	41.74	39.23	5.43	1.67	0.42	1.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	36.09	21.66	0.00	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	21.24	33.25	2.77	2.77	0.00	2.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	30.16	27.32	4.55	1.14	1.14	1.14	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	25.70	22.94	9.26	1.93	0.28	1.93	0.14	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	30.32	33.43	8.81	2.07	0.26	1.30	0.26	0.26	0.00	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	23.16	30.46	9.44	1.72	0.86	0.86	0.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	14.61	12.70	12.07	2.54	0.00	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	23.75	16.01	8.27	1.87	0.27	1.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	35.02	20.35	15.27	4.49	0.60	1.80	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	21.89	12.71	7.20	1.84	0.28	0.85	0.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	30.26	26.44	6.69	2.55	0.96	0.32	0.32	0.00	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	25.21	31.40	9.51	2.21	1.77	0.88	0.00	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	20.48	19.34	13.65	2.65	0.00	2.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	27.84	23.01	9.94	2.56	0.57	1.70	0.00	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	32.45	29.25	10.32	2.95	1.47	0.74	0.49	0.98	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	22.81	6.52	11.73	8.47	0.00	1.96	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.76	12.35	8.82	1.76	0.88	1.76	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	26.81	15.86	11.24	7.78	1.44	2.02	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.96	18.55	11.54	2.89	0.41	1.24	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	21.44	11.02	12.51	4.76	0.60	1.19	0.00	0.30	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	22.60	15.07	0.00	0.00	0.00	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	42.77	32.08	16.04	0.00	0.00	1.78	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	64.40	37.79	16.76	5.59	1.31	4.27	1.31	0.33	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	66.27	19.99	8.42	4.21	1.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	69.59	38.75	14.63	3.95	1.98	3.16	0.20	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	46.57	25.15	15.83	7.45	1.86	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	67.22	25.91	17.65	2.63	0.38	1.88	0.75	0.38	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	41.28	11.72	9.59	1.07	0.27	0.80	1.60	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	61.53	34.61	16.97	4.52	1.24	2.38	0.68	0.34	0.00	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	38.31	30.94	11.79	3.68	0.74	0.74	3.68	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	58.63	34.81	17.95	6.23	0.73	1.47	0.73	0.73	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	84.00	32.67	20.22	3.11	0.00	1.56	1.56	4.67	1.56	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	82.84	38.48	16.03	3.21	1.07	3.74	1.07	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	27.05	3.86	0.00	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	52.52	36.36	20.20	5.05	0.00	2.02	2.02	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	48.91	16.02	9.28	3.37	0.42	2.11	0.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	49.03	4.09	1.36	0.00	20.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	17.80	29.25	5.72	1.27	1.27	9.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	28.34	42.92	4.86	0.81	1.62	10.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	22.66	58.91	10.57	1.51	0.00	12.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	171.31	34.26	5.71	5.71	57.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	65.25	176.17	22.84	0.00	6.52	39.15	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	57.03	14.26	0.00	9.50	9.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	150.59	62.75	12.55	12.55	37.65	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	32.96	19.60	4.96	3.23	0.65	0.00	0.43	0.00	0.86	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	37.11	29.79	3.66	4.18	0.52	1.57	1.57	1.05	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	21.36	22.69	10.01	11.35	0.00	0.67	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.86	20.45	12.94	16.69	0.42	2.50	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	45.44	40.12	10.65	4.94	0.76	2.85	0.19	0.00	0.38	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	31.92	35.11	12.77	17.55	3.19	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	22.44	19.72	10.88	10.20	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	20.21	1.84	1.84	1.84	7.35	1.84	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.00	19.67	12.56	11.30	0.84	1.26	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	29.05	22.08	7.90	10.92	0.93	1.16	0.00	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	23.78	19.19	12.16	8.11	0.00	1.08	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	31.96	22.07	17.24	6.10	0.42	1.05	0.42	0.00	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	33.40	0.00	0.00	11.13	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	24.32	17.87	7.94	8.93	1.49	0.99	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	19.49	17.86	11.37	4.33	0.00	1.89	0.00	0.27	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	27.20	30.15	11.56	9.52	0.45	2.04	0.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.03	17.47	14.04	11.92	0.16	2.12	0.00	0.00	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	32.62	31.89	10.94	4.56	0.73	2.19	1.28	0.18	0.36	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.17	24.40	9.55	7.43	0.00	1.06	0.53	0.00	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.81	18.61	7.80	7.80	0.00	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.97	27.24	7.88	1.31	0.33	4.59	0.00	1.31	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.35	19.19	11.55	8.78	0.16	1.95	0.16	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.93	29.98	14.99	5.82	0.35	2.65	0.18	0.00	0.18	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.72	34.46	6.33	10.55	2.11	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	26.66	22.07	7.82	4.60	0.46	0.46	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	23.78	26.67	8.03	9.32	0.64	0.64	0.64	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.38	26.90	8.97	1.03	1.38	5.17	1.03	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	15.17	5.06	2.53	0.00	5.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	25.40	21.39	11.81	4.23	0.67	2.90	0.00	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.86	29.64	11.01	6.35	0.42	0.85	1.27	0.00	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	27.30	24.45	10.68	3.32	0.47	0.47	0.47	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	35.20	27.04	9.01	12.02	0.86	0.43	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	45.14	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	19.66	19.99	11.66	9.66	0.67	2.00	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	14.88	19.39	4.96	5.41	0.45	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.84	23.41	4.76	5.95	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	24.14	28.79	10.22	5.57	0.00	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	19.68	27.62	8.70	3.41	0.00	0.76	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.32	21.83	5.87	8.80	0.00	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	19.17	15.25	9.59	9.15	0.44	2.18	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	21.71	13.12	7.69	4.98	0.00	0.90	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	26.46	30.87	4.41	8.82	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	28.59	28.59	7.98	7.31	0.00	0.00	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	27.78	18.85	12.90	9.42	0.99	0.99	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	15.31	13.78	3.83	8.80	0.00	0.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	44.76	42.34	13.61	5.75	0.00	2.72	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.52	18.57	8.62	5.30	0.44	1.11	0.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.75	18.97	7.45	11.52	0.00	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	30.66	0.00	5.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	37.80	35.36	10.36	10.97	1.22	1.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.11	15.42	7.24	5.35	0.00	0.31	0.31	0.63	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.61	25.42	11.80	6.36	0.00	2.12	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	19.78	15.82	12.66	7.12	0.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	19.27	17.00	4.53	0.00	0.00	3.40	0.00	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	25.29	5.06	5.06	0.00	5.06	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	34.91	30.44	5.59	4.10	1.24	0.50	0.37	0.00	0.25	0.25
Myoblast, donor2	11322-117D8	50.06	52.74	6.90	4.99	2.11	0.58	2.69	0.38	0.96	0.38
Myoblast, donor3	11398-118D3	49.61	37.16	10.76	6.39	1.35	1.18	0.00	0.34	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	120.10	141.12	37.07	46.11	3.79	3.65	0.88	1.75	1.46	1.46
Natural Killer Cells, donor1	11230-116C6	50.13	38.44	19.99	10.46	36.90	3.08	0.00	0.31	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	42.82	28.35	22.62	17.49	47.34	4.22	1.21	0.00	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	58.53	29.82	23.56	9.94	52.46	8.10	0.37	0.37	0.18	0.00
Neural stem cells, donor1	11275-116H6	88.56	53.35	23.23	20.32	3.99	2.54	0.36	0.73	0.73	0.00
Neural stem cells, donor2	11352-117H2	65.47	32.74	9.63	21.18	9.63	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	104.69	34.14	11.38	21.62	10.24	0.00	2.28	1.14	0.00	1.14
Neurons, donor2	11574-120E8	67.59	20.26	7.71	23.12	4.40	0.44	0.44	0.22	0.00	1.10
Neurons, donor3	11655-122E8	105.24	46.04	9.87	27.13	3.29	0.00	1.64	2.47	0.00	0.00
Neutrophils, donor1	11233-116C9	54.75	35.26	41.76	12.99	4.64	6.50	1.86	0.00	1.86	0.00
Neutrophils, donor2	11314-117C9	34.79	17.39	34.79	14.49	2.90	14.49	8.70	2.90	2.90	5.80
Neutrophils, donor3	11390-118C4	54.36	50.70	57.42	33.60	4.89	12.22	0.00	0.00	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	55.45	72.19	5.46	7.60	1.66	0.36	0.36	0.47	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	29.63	37.77	6.19	6.84	0.33	0.00	1.63	0.65	0.33	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	44.32	37.10	5.21	7.42	1.60	0.00	0.60	0.00	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	34.83	33.17	6.06	5.37	0.96	1.24	1.51	0.83	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	49.36	30.11	7.67	2.46	0.43	0.87	1.16	1.45	0.14	1.88
Olfactory epithelial cells, donor3	11935-125I9	32.35	25.65	6.13	2.16	0.45	0.68	0.79	0.57	0.00	0.34
Olfactory epithelial cells, donor4	11936-126A1	44.61	30.00	8.67	9.45	1.17	0.49	0.49	0.29	0.00	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	66.20	39.72	15.65	14.44	1.20	0.00	0.00	1.20	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	31.48	34.24	7.66	3.19	0.85	0.85	0.21	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	18.29	18.29	5.72	3.43	0.00	1.14	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	31.66	26.69	6.21	4.34	0.00	1.86	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	43.78	38.70	2.15	7.43	0.59	0.00	0.20	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	75.85	56.19	3.51	14.05	5.62	0.00	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	53.50	48.34	5.87	9.95	1.42	0.18	0.71	0.00	0.00	0.36
Pancreatic stromal cells, donor1	11249-116E7	55.34	42.79	8.17	6.82	2.44	0.93	1.18	0.51	0.17	0.25
Pericytes, donor1	11491-119E6	28.04	24.14	9.57	7.23	0.33	1.22	0.22	0.11	0.22	0.00
Pericytes, donor2	11571-120E5	37.58	30.11	5.89	9.73	0.68	0.00	0.45	0.23	0.00	0.68
Pericytes, donor3	11652-122E5	35.81	50.86	5.70	8.14	1.22	0.00	0.41	0.20	1.22	0.61
Perineurial Cells, donor1	11499-119F5	50.75	39.33	5.09	7.80	1.58	0.23	0.23	0.11	0.00	0.23
Perineurial Cells, donor2	11579-120F4	56.59	59.99	6.26	10.40	1.66	0.83	0.28	0.18	0.00	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	71.08	34.11	25.50	7.33	5.10	2.87	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	60.73	27.18	25.71	3.92	15.43	8.08	2.69	0.24	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	66.91	29.77	23.55	6.21	2.33	6.34	0.65	0.26	0.26	0.00
Placental Epithelial Cells, donor1	11278-116H9	58.83	27.98	17.46	6.94	2.15	2.87	0.00	0.24	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	26.61	18.85	9.98	6.65	0.00	1.11	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	38.87	19.44	11.98	13.74	1.57	0.39	0.79	0.39	0.00	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	14.87	11.08	3.48	1.90	0.32	0.00	0.95	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	24.39	13.69	3.94	2.81	0.19	0.19	0.19	0.00	0.75	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	49.47	19.32	4.70	2.22	0.39	0.78	0.39	0.00	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	40.08	24.32	6.75	4.95	0.90	0.00	0.68	0.23	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	25.79	19.82	8.74	2.13	0.21	0.53	0.43	0.43	0.00	0.43
Preadipocyte - omental, donor2	11329-117E6	32.30	20.51	5.24	4.80	0.87	0.87	0.00	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	38.25	17.62	4.87	2.15	0.14	0.43	0.00	0.72	0.86	0.00
Preadipocyte - perirenal, donor1	11469-119C2	21.65	13.78	5.91	0.98	0.00	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	40.54	37.78	4.91	4.30	2.15	0.31	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	90.13	115.10	9.21	13.28	3.72	0.18	6.55	4.07	0.18	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	61.64	53.98	3.92	6.98	1.02	0.68	2.21	1.36	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	84.58	81.88	8.38	8.10	3.07	0.47	0.37	1.02	0.00	0.93
Preadipocyte - visceral, donor2	11357-117H7	47.40	40.04	12.42	8.28	1.84	0.46	4.60	1.38	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	64.26	67.71	7.63	7.63	3.03	0.42	2.51	1.46	0.10	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	116.16	130.19	8.00	45.41	4.37	1.81	3.32	0.75	0.30	0.91
Prostate Epithelial Cells, donor2	11331-117E8	34.94	27.08	3.11	10.83	0.68	0.54	1.49	0.54	0.00	0.81
Prostate Epithelial Cells, donor3	11404-118D9	43.85	41.70	14.45	2.88	0.12	0.49	1.47	0.67	0.55	0.43
Prostate Stromal Cells, donor1	11254-116F3	52.17	51.37	4.44	7.97	3.76	0.00	0.23	0.34	0.11	0.11
Prostate Stromal Cells, donor2	11332-117E9	56.66	51.28	8.96	8.79	4.84	0.90	2.51	1.26	0.36	0.90
Prostate Stromal Cells, donor3	11405-118E1	32.43	34.41	5.42	6.05	1.15	0.94	1.88	0.73	0.94	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	55.11	52.19	15.33	12.77	0.73	2.19	0.00	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	56.49	49.90	15.11	15.46	1.66	0.97	0.69	0.28	0.00	0.28
Renal Epithelial Cells, donor1	11517-119H5	39.56	29.42	8.62	13.70	0.51	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	49.08	45.52	14.94	33.43	2.85	1.42	1.42	0.00	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	62.57	50.60	13.55	15.99	2.01	0.53	0.64	0.21	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	36.09	32.00	17.70	19.06	0.68	6.81	1.36	0.68	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	53.91	38.14	18.60	17.65	1.21	6.47	0.54	0.27	0.54	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	68.38	57.28	11.77	15.32	4.22	2.66	0.89	0.22	0.22	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	11.98	6.65	6.65	8.65	0.67	5.32	0.67	0.67	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	43.58	38.74	10.12	16.07	0.88	0.22	0.22	0.22	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	56.43	45.77	16.30	20.06	0.63	0.63	1.25	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	25.24	21.64	9.99	12.76	1.11	0.00	0.83	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	77.04	66.03	19.06	20.67	4.83	1.61	0.81	0.54	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	54.82	48.92	12.65	13.07	2.95	1.27	0.84	0.42	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	69.23	56.89	10.41	30.47	3.28	0.58	1.16	0.77	1.54	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	65.60	33.19	22.30	20.74	4.15	3.63	0.00	0.26	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	46.33	32.12	11.37	17.05	4.26	1.71	0.00	0.00	0.85	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	27.79	44.25	13.38	17.50	4.12	2.06	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	47.67	42.15	7.53	9.28	2.76	2.51	1.76	0.00	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	74.44	62.81	27.66	16.17	5.48	8.02	1.47	0.27	0.00	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	20.55	11.61	9.83	14.29	4.47	0.00	0.00	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	63.84	22.01	8.26	4.95	7.15	3.85	1.65	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	39.44	15.08	13.34	4.64	4.06	1.74	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	48.37	9.23	8.71	8.06	2.86	0.78	0.52	0.00	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	44.99	8.74	10.82	10.92	1.79	1.09	0.50	0.40	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	54.32	12.38	7.81	11.49	3.68	1.12	0.22	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	88.44	16.99	10.17	12.03	3.35	0.50	0.74	0.37	0.00	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	56.41	11.19	11.19	12.47	4.55	0.70	0.82	0.23	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	59.17	15.49	13.17	11.09	3.24	1.16	0.46	0.00	0.46	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	44.36	8.49	9.99	5.61	1.64	0.82	0.68	0.27	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	54.16	10.29	10.74	8.47	3.48	0.61	0.15	0.15	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	46.05	8.24	10.03	13.98	3.94	1.08	0.36	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	53.22	9.04	13.05	7.75	2.01	1.15	1.43	0.29	0.14	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	50.44	10.09	10.41	9.12	2.25	0.43	1.82	0.43	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	55.54	8.63	11.73	9.51	2.66	1.77	0.22	0.22	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	40.72	8.99	9.18	7.65	0.57	0.19	0.00	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.46	7.92	9.60	9.60	1.86	1.30	0.47	0.09	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	62.01	13.72	11.84	9.77	3.57	0.94	0.38	0.00	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	38.22	9.42	11.01	8.63	3.18	1.06	0.27	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	44.39	7.98	10.12	8.86	1.85	0.97	0.78	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	52.32	10.31	12.60	10.12	2.10	1.15	0.57	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	42.50	11.21	10.25	7.69	1.39	0.43	0.64	0.21	0.11	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	38.96	8.41	12.05	10.09	1.68	1.12	0.56	0.00	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	42.55	7.52	12.99	9.06	2.05	1.03	1.37	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	47.41	12.40	11.67	6.38	2.19	0.73	0.18	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	44.02	7.11	10.42	9.69	1.23	0.74	0.61	0.12	0.00	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	57.49	10.34	13.30	10.34	2.15	1.75	1.21	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	58.26	14.15	12.03	4.72	1.65	0.24	0.71	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	52.38	8.13	12.50	8.33	2.18	0.99	1.39	0.40	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	46.77	11.93	14.73	8.18	1.64	0.70	0.70	0.47	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	58.06	11.40	11.40	6.22	0.62	0.21	0.62	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	43.14	10.40	12.83	8.85	0.88	1.11	1.77	1.11	0.22	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	48.88	8.98	10.86	10.24	1.67	1.25	0.42	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	62.18	12.52	8.75	6.86	2.29	0.54	0.94	0.40	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	42.91	6.30	10.73	9.20	1.53	0.68	0.34	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	50.71	12.34	12.72	7.90	3.08	1.35	0.77	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	57.26	12.72	8.77	7.39	3.27	0.34	0.69	0.00	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	38.00	7.54	9.19	9.33	2.06	1.10	0.14	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	43.83	9.69	9.85	8.87	1.97	0.66	0.49	0.66	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	38.01	13.46	7.33	6.82	2.73	1.02	0.51	0.68	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	55.48	12.28	9.91	9.77	2.81	1.33	1.18	0.30	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	41.85	8.26	8.53	8.53	1.87	1.07	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	39.68	12.31	14.10	6.64	3.18	1.66	0.41	0.14	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	53.10	10.24	9.76	10.95	2.86	0.95	1.19	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	43.33	8.87	15.72	11.69	3.43	2.02	0.40	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	45.02	12.43	15.35	8.85	3.11	1.32	0.66	0.66	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	49.61	16.77	17.47	16.77	4.54	1.40	0.70	1.05	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	41.10	11.79	9.97	8.46	2.72	2.12	0.60	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.49	13.22	13.10	10.04	3.30	0.73	0.86	0.86	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	67.68	19.36	20.09	15.72	5.39	3.20	0.15	0.44	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	57.19	12.17	11.56	13.39	4.26	1.22	0.61	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	50.03	11.75	15.97	11.45	4.22	0.60	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	48.40	18.10	10.86	16.29	4.07	0.68	2.26	0.90	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	49.42	21.27	13.78	16.18	8.39	1.50	1.50	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	46.17	19.48	11.22	13.34	4.37	1.65	0.83	0.12	0.12	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	42.26	15.15	12.38	14.51	3.84	1.71	0.43	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	49.28	10.22	12.62	13.82	5.41	0.60	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	47.02	36.30	6.58	15.05	4.14	0.00	0.56	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	54.44	51.04	3.40	13.61	6.80	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	51.26	31.55	6.57	14.02	1.75	0.44	1.10	0.66	0.00	1.10
Sebocyte, donor1	11220-116B5	81.07	58.61	3.83	2.19	1.64	0.00	0.55	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	49.63	49.17	2.76	2.30	2.30	0.00	0.92	1.38	0.92	1.38
Sebocyte, donor3	11378-118B1	39.16	30.09	5.77	4.33	0.41	0.62	1.44	0.41	0.00	0.21
Sertoli Cells, donor1	11255-116F4	41.41	33.13	9.94	4.97	0.00	0.00	0.00	1.66	0.00	1.66
Sertoli Cells, donor2	11333-117F1	25.42	53.66	2.82	5.65	0.00	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	75.05	42.32	3.52	5.37	2.11	0.09	0.18	0.35	0.00	0.09
Skeletal Muscle Cells, donor2	11358-117H8	10.12	8.67	12.29	4.34	1.45	2.89	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	49.33	55.18	14.21	15.88	4.18	1.67	0.00	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	77.76	121.12	5.66	11.31	5.03	0.31	1.89	0.94	1.10	0.47
Skeletal Muscle Cells, donor5	11455-119A6	82.80	98.40	5.80	7.88	4.16	0.59	1.34	1.34	0.59	0.30
Skeletal Muscle Cells, donor6	11459-119B1	91.11	109.27	8.93	17.08	5.08	0.15	1.69	0.46	1.39	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	74.60	101.31	5.80	6.68	1.89	0.76	0.76	0.38	1.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	52.65	87.47	5.28	9.42	1.43	0.14	1.43	0.57	0.57	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	95.04	106.75	8.43	12.60	3.97	0.60	2.08	0.60	0.69	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	58.30	47.52	3.54	6.07	1.26	0.17	0.08	0.67	0.00	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	49.94	15.20	7.24	5.07	2.17	0.00	0.00	0.00	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	27.38	20.64	4.13	4.95	0.69	0.28	0.83	0.14	0.00	0.00
Skin - palm, donor1	10286-104F7	59.09	0.00	16.12	8.06	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.92	36.18	4.32	1.87	0.43	0.29	0.86	0.14	0.14	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	22.90	97.33	4.09	0.82	0.00	2.45	0.00	0.00	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	29.34	46.22	5.71	4.67	1.30	0.13	0.26	0.00	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	42.68	56.72	4.03	2.09	1.25	0.42	1.11	0.42	0.00	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	28.41	40.79	4.22	3.80	0.42	0.28	0.28	0.00	0.28	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	60.47	73.58	8.67	4.44	4.02	0.42	0.21	0.00	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	37.18	36.13	6.00	3.15	0.67	0.22	0.15	0.22	0.07	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	17.28	21.60	3.70	1.54	0.62	0.00	0.00	0.93	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.12	21.79	2.45	1.78	0.67	0.22	0.44	0.89	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	34.09	25.28	4.11	4.70	0.00	0.00	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	33.37	30.28	5.30	3.09	1.55	0.44	0.44	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	28.75	30.71	3.54	1.18	0.39	0.39	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	33.22	37.86	4.64	6.18	0.77	0.00	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	54.04	31.02	5.00	8.01	1.00	0.00	2.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	33.93	19.43	2.00	2.79	0.67	0.27	0.27	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	45.88	37.02	6.43	4.88	1.99	0.22	1.55	0.89	0.00	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	34.82	32.01	5.38	5.63	1.02	0.00	0.51	0.13	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	45.26	36.14	7.81	6.19	1.95	2.93	0.33	0.33	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	36.92	36.62	4.13	6.20	0.30	0.59	0.30	0.30	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	35.02	25.48	5.69	6.12	0.43	0.71	0.28	0.28	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	30.26	39.04	5.21	7.48	1.95	0.00	0.00	0.16	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	55.71	62.41	9.13	7.92	0.30	1.52	1.22	0.61	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	39.40	45.97	3.79	5.05	1.77	0.25	0.00	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	312.16	18.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	21.46	25.27	3.81	4.29	0.48	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	45.13	42.18	7.67	6.05	1.33	0.44	0.15	0.44	0.59	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	40.03	47.35	7.75	7.32	0.86	0.86	1.51	0.43	0.43	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	58.36	49.75	8.92	7.98	1.05	1.15	0.73	0.73	0.52	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	36.66	29.85	3.71	5.88	0.77	0.31	0.00	0.15	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	15.09	26.95	2.16	1.08	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	31.68	24.81	7.17	6.87	0.90	0.00	0.90	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	43.70	54.97	5.80	9.22	2.39	0.00	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	42.72	56.86	6.28	8.64	0.79	0.47	1.26	0.24	0.08	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	25.26	17.31	3.42	2.52	0.50	0.30	0.70	0.20	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	39.37	30.95	9.10	6.83	0.68	0.46	1.82	0.68	0.00	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	20.53	23.55	6.64	4.23	0.00	0.60	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	101.47	103.59	7.95	19.34	7.68	0.26	1.59	0.79	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	47.01	41.28	7.32	7.46	1.60	0.27	0.27	0.27	0.13	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	35.31	36.31	6.01	4.51	1.13	0.50	1.75	1.00	0.75	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	30.69	30.69	6.34	4.82	0.25	0.51	0.25	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	50.96	43.72	3.32	6.78	2.71	0.45	0.45	0.15	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	29.26	32.26	1.50	3.75	0.00	0.75	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	23.26	18.09	6.46	16.80	1.29	2.58	5.17	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	38.14	29.30	2.79	9.30	1.40	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	25.75	19.69	3.03	2.52	1.01	0.50	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.94	18.80	2.19	2.82	0.31	0.00	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	20.06	34.81	4.13	5.31	1.18	0.29	0.88	0.00	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	63.31	63.15	5.66	10.83	2.92	0.08	0.08	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	37.84	35.04	6.54	6.54	0.47	0.93	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	25.62	20.87	4.46	3.60	0.14	0.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	37.99	29.06	6.12	10.45	2.04	1.27	1.02	0.51	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	30.46	30.84	6.96	8.46	0.75	0.38	1.50	0.19	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	60.93	51.71	6.71	9.08	1.96	0.42	0.14	0.00	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	39.55	44.16	4.02	3.69	0.84	0.17	0.17	0.08	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.86	20.48	4.76	0.48	0.95	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	28.14	16.64	4.65	2.20	0.00	0.00	0.24	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	49.05	45.74	4.20	2.87	0.22	0.22	0.00	0.00	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	42.72	32.77	7.61	7.02	0.88	0.59	0.29	0.00	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	27.60	33.62	7.00	4.86	0.00	0.58	0.19	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	16.13	10.84	5.29	2.12	0.00	0.53	0.53	0.26	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	33.85	38.68	2.98	2.23	0.74	2.23	1.12	0.37	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	25.15	21.20	6.83	2.52	0.36	1.44	0.72	1.08	0.00	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	20.44	19.59	9.08	3.12	0.28	1.99	0.00	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	48.05	42.54	5.51	10.24	2.36	0.79	0.79	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	25.40	18.28	7.11	2.54	0.51	0.51	0.25	0.76	0.25	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	21.16	21.96	5.59	4.79	0.80	0.00	0.00	0.00	0.00	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	25.08	53.50	7.52	2.93	1.25	1.25	0.84	0.00	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	36.21	37.13	8.25	7.33	0.92	1.83	3.21	0.46	0.46	0.46
Synoviocyte, donor1	11291-117A4	52.52	26.43	4.38	3.20	0.34	0.00	0.17	0.17	0.00	0.67
Synoviocyte, donor2	11368-117I9	50.12	41.24	7.21	4.02	0.50	0.84	1.34	0.50	0.34	0.50
Synoviocyte, donor3	11440-118H9	38.43	30.83	5.81	2.23	0.89	0.89	0.67	0.00	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	85.76	73.97	11.43	23.23	1.43	1.07	0.36	0.36	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	33.69	3.96	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	30.56	28.02	7.41	9.96	0.00	0.46	0.69	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	55.20	54.34	6.45	3.30	0.50	0.07	0.14	0.22	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	34.79	40.59	5.41	4.64	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	29.21	43.52	5.73	2.29	1.15	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	70.62	57.08	29.16	17.35	6.77	7.26	0.25	0.74	0.00	0.12
Urethra, donor2	10319-105A4	73.74	19.78	17.98	19.78	1.80	3.60	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	35.33	37.19	5.84	5.58	0.80	0.00	0.27	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	34.45	36.85	6.01	5.21	0.40	0.00	0.00	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	30.94	28.19	3.90	6.19	0.23	0.23	0.92	0.92	0.46	0.23
Urothelial cells, donor0	11216-116B1	56.39	60.18	7.13	4.68	0.22	0.22	0.22	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	96.10	55.17	32.92	10.68	0.89	1.78	0.00	0.89	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	84.35	74.34	32.88	11.44	0.00	0.00	1.43	1.43	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	71.87	33.54	29.43	11.64	0.00	0.68	1.37	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	109.16	44.42	18.59	8.61	0.69	0.34	1.72	0.69	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	103.42	44.16	19.75	7.55	1.16	0.58	2.32	0.00	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	89.55	62.47	20.82	11.45	0.00	2.08	0.00	1.04	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	73.42	55.99	30.29	15.60	1.84	2.75	0.00	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	83.07	50.21	27.39	15.52	0.91	2.74	2.74	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	65.13	59.34	27.88	20.85	17.52	3.82	1.85	2.34	2.47	1.11
Wilms' tumor cell line:HFWT	10597-108E3	35.20	212.09	0.00	0.00	29.04	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	123.18	66.76	0.00	0.00	11.17	0.00	1.12	0.56	1.40	0.28
achilles tendon, donor2	10292-104G4	57.86	24.80	24.80	12.40	10.33	10.33	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	97.14	43.85	14.02	11.47	2.55	2.04	0.51	0.76	2.04	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	184.35	91.48	59.67	42.02	11.38	2.55	0.46	0.70	2.32	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	159.54	69.56	39.41	39.89	15.43	2.02	0.59	0.71	2.37	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	142.59	85.72	36.46	44.90	16.33	0.82	1.36	1.09	3.27	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	174.27	103.44	11.81	22.77	13.21	2.25	3.09	1.41	1.41	2.25
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	149.94	121.18	29.61	27.92	14.17	1.69	0.85	0.21	0.63	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	81.94	57.71	23.68	12.79	0.54	2.99	1.63	1.36	0.54	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	133.51	144.97	14.98	25.12	19.83	1.32	2.64	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	162.12	133.94	8.58	2.04	14.29	0.41	5.31	1.63	0.82	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	144.45	110.66	48.93	26.40	7.77	2.72	1.16	1.16	3.11	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	112.24	115.18	18.77	23.18	7.91	1.47	6.07	1.66	0.92	2.76
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	109.21	62.41	0.00	0.00	15.60	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	92.49	100.39	27.89	41.36	8.37	0.93	1.86	1.16	0.70	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	173.46	127.90	54.37	25.89	9.58	4.66	4.14	2.33	2.33	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	161.61	98.49	36.24	21.33	9.35	0.58	3.51	1.17	3.51	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	52.98	29.28	26.03	7.44	1.86	5.11	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	69.09	36.60	0.00	0.00	0.00	0.00	2.06	1.23	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	69.68	50.95	58.01	29.16	7.67	1.84	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	96.01	77.23	36.27	14.08	8.11	3.41	0.00	0.43	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	90.99	67.94	31.85	12.44	8.49	1.82	0.30	0.30	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	83.77	81.12	33.70	13.96	14.68	2.89	0.96	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	102.46	68.38	8.46	6.24	3.79	0.22	2.23	1.34	0.67	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	92.39	99.73	19.35	29.69	14.01	1.00	0.67	0.00	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	50.17	50.17	33.45	37.16	9.29	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	117.14	62.15	31.26	29.38	3.01	0.38	1.51	0.38	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	93.33	91.59	46.67	32.71	6.11	4.80	0.44	0.00	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	44.99	35.61	37.49	1.87	5.62	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	71.36	44.74	22.61	19.78	8.71	8.95	0.71	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	66.70	48.55	20.32	2.95	0.78	3.41	0.47	0.00	0.00	0.47
adipose, donor1	10184-103D4	62.16	26.97	13.49	7.62	1.17	1.17	1.76	1.76	0.59	2.35
adipose, donor2	10185-103D5	26.36	6.89	11.76	16.63	8.52	0.00	0.41	0.00	0.81	0.00
adipose, donor3	10186-103D6	47.65	17.15	18.52	15.52	14.98	1.09	0.82	0.27	0.54	0.82
adipose, donor4	10187-103D7	123.08	36.40	19.94	22.54	1.73	1.73	4.33	1.73	0.00	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	58.24	55.39	18.62	33.14	5.05	1.89	0.32	0.47	0.47	0.47
adrenal gland, adult, pool1	10081-102A9	47.29	21.83	36.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	100.45	55.90	25.48	16.81	4.94	3.20	0.00	0.13	2.93	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	113.98	98.61	50.74	35.02	25.01	3.93	1.43	2.14	1.79	0.71
amniotic membrane cells, donor1	12235-129G3	52.63	22.49	17.62	4.41	2.78	1.39	0.23	0.00	0.23	0.93
amniotic membrane cells, donor2	12236-129G4	96.70	30.09	27.05	28.74	10.82	0.68	0.00	0.34	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	54.21	21.80	12.08	6.78	3.24	1.18	0.59	0.59	0.29	0.88
amygdala - adult, donor10196	10167-103B5	21.34	11.86	9.49	4.74	0.00	1.19	1.19	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	49.68	14.19	11.56	5.68	1.42	2.43	1.22	0.61	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	33.25	19.04	6.78	5.16	4.84	2.58	0.32	0.00	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	51.19	15.79	7.39	5.98	0.51	0.64	0.13	0.38	0.25	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	93.99	92.22	18.53	30.00	3.53	2.87	0.66	0.88	1.32	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	84.18	62.13	6.01	28.06	42.76	0.00	1.00	1.00	0.67	0.67
aorta, adult, pool1	10052-101G7	56.68	28.44	11.57	6.67	9.02	1.37	1.18	0.59	0.39	0.39
appendix, adult	10189-103D9	64.43	57.83	28.33	18.63	3.10	0.78	2.33	0.78	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	74.63	40.93	23.04	20.64	16.16	4.13	0.34	1.03	0.69	0.00
artery, adult	10190-103E1	43.48	12.23	4.08	10.87	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	24.34	73.30	37.52	45.92	0.00	2.46	0.58	0.58	1.59	0.14
b cell line:RPMI1788	10427-106D4	65.28	74.20	25.73	5.95	5.80	5.80	0.45	0.15	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	31.63	15.81	5.55	1.66	0.00	0.00	0.28	0.28	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	91.59	73.33	22.43	15.28	4.37	3.08	0.50	0.40	1.09	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	118.84	64.78	29.96	7.53	0.33	2.18	0.50	0.33	2.18	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	84.44	66.55	21.81	11.18	8.95	0.00	0.00	0.56	0.56	0.56
bladder, adult, pool1	10011-101C2	78.66	41.72	9.45	7.28	0.54	0.98	0.76	0.11	0.11	0.00
blood, adult, pool1	10053-101G8	46.51	26.58	26.58	19.93	2.21	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	26.55	12.85	9.42	2.57	0.00	0.00	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	34.42	26.32	9.45	6.75	1.35	0.67	2.70	0.67	0.67	1.35
brain, adult, donor1	10084-102B3	27.68	4.10	15.38	4.10	1.03	3.08	0.00	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	31.96	8.02	9.58	5.12	2.12	1.78	0.45	0.11	0.00	0.67
brain, fetal, pool1	10085-102B4	37.40	5.34	24.04	13.36	0.00	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	103.07	69.05	40.97	76.64	11.23	6.61	1.65	1.65	2.31	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	90.62	55.80	47.81	51.30	6.87	12.86	0.00	0.25	0.87	0.00
breast, adult, donor1	10080-102A8	61.24	29.04	28.41	11.36	1.26	5.68	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	120.56	80.03	15.12	13.21	7.75	0.25	1.40	1.27	2.41	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	53.50	18.55	8.97	15.77	9.90	0.31	0.00	0.62	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	58.02	22.56	0.00	0.00	2.76	0.00	0.92	0.69	0.46	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	25.42	25.90	7.02	8.72	6.54	2.91	0.24	0.48	1.45	0.00
carcinoid cell line:NCI-H1770	10703-109H1	51.72	18.34	19.28	20.69	13.16	0.47	0.00	0.94	1.88	0.94
carcinoid cell line:NCI-H727	10735-110B6	40.14	24.72	11.81	22.75	7.66	4.70	0.11	0.11	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	41.51	34.54	3.49	16.16	10.14	0.00	0.95	1.58	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	99.28	65.21	31.68	54.30	33.54	6.65	3.46	1.86	0.80	2.40
caudate nucleus - adult, donor10196	10177-103C6	23.03	18.42	10.36	1.15	12.66	8.06	0.00	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	39.49	13.89	8.53	4.52	13.55	2.68	0.84	0.67	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	17.58	3.82	5.35	3.06	10.70	1.53	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	37.72	24.17	10.25	6.59	21.97	5.49	0.73	0.37	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	37.87	11.65	32.05	0.00	2.91	5.83	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	79.00	9.39	27.54	13.24	0.64	3.63	1.07	0.43	0.21	0.21
cerebellum, adult, pool1	10083-102B2	37.94	3.45	20.35	8.97	1.03	0.34	1.03	0.69	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	52.31	8.30	9.96	12.45	1.66	0.00	0.83	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	32.02	5.80	9.33	4.03	7.56	2.27	0.25	0.25	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	36.54	8.04	11.69	2.19	19.73	1.46	1.46	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	129.55	89.86	19.70	17.25	4.31	1.58	1.58	0.14	0.86	0.58
cervical cancer cell line:ME-180	10553-107I4	83.52	56.18	17.07	19.89	3.98	0.83	0.17	0.17	0.17	0.00
cervix, adult, pool1	10013-101C4	74.33	26.77	8.92	8.82	2.52	1.05	0.31	0.10	0.00	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	70.92	28.01	20.90	19.09	2.79	7.52	0.28	0.42	0.14	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	14.37	2.61	3.92	0.00	2.61	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	86.00	82.02	11.43	33.93	2.73	1.49	0.50	1.49	1.24	0.62
choriocarcinoma cell line:SCH	10785-110H2	96.84	128.14	16.39	56.55	3.33	0.99	0.86	1.85	3.08	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	66.88	73.05	6.64	33.68	1.66	0.24	0.47	0.47	1.19	0.00
chorionic membrane cells, donor1	12238-129G6	55.27	34.76	12.82	1.71	4.27	0.85	0.28	0.00	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	59.36	30.03	13.42	17.00	1.29	0.89	0.50	0.60	0.20	0.40
chorionic membrane cells, donor3	12240-129G8	75.83	53.85	10.99	4.95	2.75	0.55	0.00	1.65	1.65	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	96.94	66.65	0.00	0.00	15.15	0.00	1.01	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	92.02	75.69	0.00	0.00	9.22	0.00	1.34	0.00	0.96	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	70.75	56.81	23.44	39.28	5.28	3.17	0.63	0.63	1.48	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	89.11	94.76	8.99	27.22	7.19	1.28	2.05	2.05	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	92.88	111.75	9.68	35.31	9.43	1.45	2.66	1.21	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	103.23	122.98	9.57	30.13	12.01	1.02	4.68	1.22	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	152.53	129.27	10.89	27.97	16.20	0.29	1.18	0.29	2.65	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	107.12	89.39	21.89	26.06	5.99	3.13	0.26	0.26	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	69.03	34.29	12.34	16.92	11.43	0.23	1.60	1.37	2.06	1.60
clear cell carcinoma cell line:TEN	10636-108I6	53.09	32.79	0.00	0.00	54.48	0.00	0.35	0.69	1.56	0.00
colon carcinoma cell line:CACO-2	10513-107D9	133.99	90.79	18.30	55.83	4.21	5.86	0.37	0.18	2.20	0.37
colon carcinoma cell line:COLO-320	10420-106C6	96.16	50.93	0.00	0.00	4.18	0.00	0.76	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	78.54	38.08	17.85	13.09	3.57	2.38	0.00	3.57	0.00	1.19
colon, adult, pool1	10014-101C5	73.91	45.12	14.22	15.86	1.65	12.69	0.35	0.12	0.00	0.00
colon, fetal, donor1	10070-101I7	56.85	29.66	14.21	30.28	3.09	3.71	1.85	1.24	0.00	1.24
common myeloid progenitor CMP, donor1	12130-128D6	155.84	73.34	50.42	9.17	96.25	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	275.40	100.15	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	88.39	131.73	17.00	16.57	19.12	6.37	0.00	1.70	2.97	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	108.82	151.99	13.43	19.17	11.92	2.11	0.75	0.91	1.81	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	115.91	162.30	16.78	23.55	12.97	2.82	0.42	0.56	2.82	0.42
corpus callosum, adult, pool1	10042-101F6	74.74	6.85	20.45	16.58	22.00	2.87	0.22	0.22	0.00	0.11
cruciate ligament, donor2	10295-104G7	83.48	25.12	18.64	4.05	1.62	1.62	1.62	0.81	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	32.91	16.05	13.64	5.62	1.61	0.80	1.61	0.00	0.80	0.80
diencephalon, adult	10193-103E4	30.24	2.64	8.64	6.72	5.28	1.20	0.72	0.24	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	142.59	111.59	26.63	9.41	15.38	0.69	5.74	1.61	2.07	2.30
ductal cell carcinoma cell line:KLM-1	10438-106E6	92.06	73.60	0.00	0.00	10.77	0.00	0.26	0.00	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	53.20	69.57	5.30	4.33	4.81	3.85	0.00	0.00	0.72	0.72
ductus deferens, adult	10196-103E7	47.34	19.93	14.95	7.48	1.50	1.99	1.00	0.00	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	67.69	31.69	14.40	25.92	1.44	25.92	1.44	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	74.30	36.05	16.18	22.81	2.21	5.89	1.47	0.00	0.00	2.94
dura mater, adult, donor1	10041-101F5	50.96	36.42	16.02	10.57	3.55	3.06	0.50	0.33	0.00	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	84.17	55.52	21.99	24.21	7.33	6.22	0.44	0.44	0.44	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	95.43	52.02	16.77	35.25	4.44	1.43	0.72	0.43	1.29	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	30.21	24.05	17.27	17.88	3.70	4.32	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	46.31	23.61	9.08	7.27	1.21	1.21	0.00	0.30	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	42.61	16.98	13.58	11.11	1.23	2.47	0.31	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	53.85	19.70	5.25	13.13	1.31	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	74.41	37.54	0.00	0.00	2.68	0.00	0.34	0.34	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	87.54	55.82	23.38	29.36	1.81	0.18	0.54	0.00	1.99	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	57.25	55.96	8.04	9.33	10.29	0.00	1.77	1.29	2.25	0.80
epidermoid carcinoma cell line:A431	10426-106D3	65.47	86.04	0.00	0.00	10.34	0.00	0.11	0.11	0.67	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	112.63	110.76	0.00	0.00	7.92	0.00	0.77	0.33	0.88	0.11
epididymis, adult	10197-103E8	49.40	22.81	10.67	11.09	16.74	0.84	1.67	0.21	0.00	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	63.51	37.26	30.69	18.81	11.53	4.44	0.71	0.53	1.06	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	38.54	21.63	8.26	4.33	6.29	0.00	0.00	0.00	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	143.50	105.50	2.23	0.66	10.62	0.13	4.98	3.15	0.52	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	125.58	94.09	1.57	1.57	6.99	0.30	3.05	1.77	0.69	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	145.97	100.04	1.57	0.56	8.63	0.22	5.49	2.69	0.22	0.67
esophagus, adult, pool1	10015-101C6	61.05	38.22	10.72	7.33	1.49	0.64	0.42	0.42	0.00	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	95.43	67.38	14.40	10.77	6.64	7.51	0.38	0.13	0.38	0.50
eye - muscle inferior rectus, donor1	10272-104E2	33.80	14.49	9.66	9.66	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	8.42	16.83	6.31	0.00	2.10	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	16.37	5.95	7.44	2.98	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	45.86	11.46	11.46	11.46	0.00	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	67.04	13.12	18.95	20.40	1.46	2.91	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	58.47	19.07	10.93	39.91	1.53	1.53	2.03	2.54	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	68.86	52.19	6.67	10.00	3.59	0.13	0.64	0.77	1.03	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	59.35	40.36	17.09	27.30	8.31	0.71	0.00	0.24	0.24	0.71
frontal lobe, adult, pool1	10040-101F4	37.44	2.72	9.57	4.88	1.31	1.31	0.09	0.28	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	102.69	58.55	23.42	55.85	21.92	5.10	1.20	1.80	1.50	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	44.26	29.17	10.97	3.93	1.19	1.28	0.27	0.09	0.37	0.09
gall bladder, adult	10198-103E9	59.63	29.70	12.80	7.97	1.45	4.10	1.69	0.00	0.00	0.48
gamma delta positive T cells, donor1	11937-126A2	148.17	80.53	21.47	12.35	2.15	0.00	1.07	0.00	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	113.54	48.93	20.54	5.60	1.49	1.49	0.37	0.00	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	48.16	40.76	0.00	0.00	2.75	0.00	0.21	0.42	0.21	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	101.16	58.02	11.22	35.40	18.76	3.09	1.16	0.58	1.93	0.19
gastric cancer cell line:AZ521	10549-107H9	99.19	70.01	30.17	39.19	9.35	7.71	0.49	0.00	0.49	0.82
gastric cancer cell line:GSS	10560-108A2	70.47	75.96	13.73	21.05	2.75	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	49.58	41.35	12.79	26.96	49.80	4.34	2.28	0.69	2.06	0.91
giant cell carcinoma cell line:LU65	10487-107B1	110.50	120.36	21.34	10.79	4.25	3.33	0.92	0.57	1.61	1.03
giant cell carcinoma cell line:Lu99B	10433-106E1	53.74	42.55	11.90	16.80	2.10	4.76	0.28	0.14	0.70	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	55.37	48.89	18.46	26.44	15.96	2.24	0.75	0.50	1.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	57.21	24.49	24.07	16.78	5.81	3.59	0.21	0.11	0.32	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	52.66	22.33	29.49	16.01	5.62	4.77	0.14	0.14	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	51.21	37.53	10.04	13.80	5.30	0.11	0.33	0.00	0.88	0.66
glioma cell line:GI-1	10413-106B8	39.25	39.83	13.47	8.49	3.51	2.05	0.29	0.29	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	31.34	15.31	21.87	8.02	1.46	10.20	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	102.76	33.93	31.00	9.76	2.20	9.28	1.95	0.73	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	26.01	4.11	8.22	4.11	4.11	2.74	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	43.17	26.65	11.72	6.40	1.60	1.07	0.53	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	141.93	83.20	100.33	17.13	141.93	14.68	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	153.00	32.79	32.79	21.86	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	47.04	5.23	5.23	31.36	5.23	0.00	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	33.28	25.92	9.92	6.08	3.84	0.64	0.32	0.00	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	58.31	60.60	9.18	33.97	8.72	1.38	3.67	0.46	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	72.70	66.76	4.57	32.92	8.23	1.37	4.12	0.00	0.46	0.91
hIPS +CCl2, biol_rep3	14385-156C2	46.37	68.92	9.02	42.51	4.51	0.64	1.29	0.64	0.00	0.64
hIPS, biol_rep1	14380-156B6	45.99	77.61	10.06	34.49	10.06	0.00	1.44	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	61.04	68.59	14.40	28.12	5.49	0.00	1.37	0.00	0.69	2.74
hIPS, biol_rep3	14382-156B8	22.07	12.14	6.62	8.83	5.52	0.00	2.21	0.00	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	78.16	67.81	15.23	11.78	5.46	1.15	0.57	0.57	1.72	0.57
heart - mitral valve, adult	10205-103F7	49.63	23.92	9.27	5.08	2.09	1.20	0.90	0.00	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	36.87	10.72	9.15	5.49	0.00	0.52	0.00	0.26	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	79.10	55.79	24.15	0.83	3.33	9.99	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	55.30	23.67	15.51	18.57	3.47	1.22	1.02	1.63	1.84	0.20
heart, adult, diseased, donor1	10051-101G6	43.43	22.14	8.52	7.66	0.00	1.28	1.28	0.85	0.00	0.00
heart, adult, pool1	10016-101C7	38.87	22.54	12.88	3.68	0.00	0.92	0.46	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	79.58	24.85	20.13	15.71	1.54	1.44	0.31	0.21	0.10	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	28.38	18.82	4.01	5.55	0.00	0.31	0.00	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	48.76	58.27	0.00	0.00	2.38	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	94.36	87.40	10.61	48.07	10.39	6.85	3.43	2.43	0.33	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	102.44	87.87	8.62	42.48	10.32	8.13	3.76	1.58	0.24	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	105.70	95.80	11.32	50.73	10.11	8.39	3.94	1.72	0.30	1.41
hepatoma cell line:Li-7	10484-107A7	115.89	37.48	15.79	30.14	2.67	3.78	0.44	0.33	1.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	107.74	128.04	15.28	12.36	12.36	2.11	0.80	1.71	1.21	0.10
hippocampus - adult, donor10196	10169-103B7	29.34	13.25	11.36	3.79	1.89	1.89	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	57.15	12.65	17.55	7.96	5.51	4.08	2.25	0.61	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	9.96	3.98	6.97	1.99	0.50	1.49	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	25.03	16.21	8.46	3.17	2.47	2.82	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	171.51	96.43	32.96	40.89	3.05	4.27	3.66	1.83	1.22	4.27
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	110.35	61.07	32.59	57.73	6.68	2.75	3.34	0.20	0.59	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	117.81	53.83	32.24	46.21	5.59	1.52	2.03	0.76	1.27	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	60.90	16.35	23.12	29.32	1.13	0.56	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	64.04	22.98	18.85	31.50	0.52	1.55	2.84	0.77	0.52	3.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	85.79	21.64	21.26	27.71	3.04	0.76	1.52	0.38	0.00	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	53.43	22.19	21.31	22.77	8.47	1.46	2.04	0.29	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	49.12	18.10	18.74	32.96	6.89	1.94	2.37	0.22	0.00	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	59.64	22.94	27.11	22.94	9.18	1.25	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	71.27	16.58	14.21	15.39	22.73	0.95	0.95	0.24	0.71	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	73.93	25.88	12.86	21.21	23.79	0.80	0.80	0.48	0.32	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	84.16	24.91	12.12	12.12	18.85	0.67	0.00	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	118.15	60.09	25.19	48.35	3.29	2.66	2.82	0.47	0.47	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	97.77	56.99	22.60	41.27	3.44	1.97	7.37	2.46	0.00	6.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	166.70	95.13	18.33	26.18	4.36	1.75	7.85	1.75	1.75	5.24
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	67.96	18.90	21.38	28.45	1.15	0.95	0.38	0.19	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	61.05	16.57	27.91	20.06	3.05	1.74	1.74	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	59.47	17.99	17.99	13.49	1.50	1.00	2.00	0.50	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	42.58	8.48	8.48	15.64	12.81	0.38	0.57	0.38	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	47.75	9.09	10.00	17.28	13.64	0.91	0.45	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	45.11	9.40	11.90	21.93	18.48	0.00	0.63	0.31	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	54.54	15.02	8.65	7.35	29.72	0.82	0.82	0.49	0.49	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	51.68	14.81	10.45	11.03	31.06	0.29	1.16	0.00	0.29	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	46.33	16.14	13.15	11.96	37.66	0.00	1.20	0.30	0.30	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	111.96	63.37	25.49	51.54	5.17	1.11	3.88	1.11	0.37	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	108.41	60.77	26.25	58.20	2.85	1.43	3.14	0.86	0.86	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	132.70	93.50	30.62	46.14	8.17	2.45	2.86	2.04	1.63	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	63.02	30.28	21.48	24.29	3.52	0.70	1.76	0.00	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	60.18	27.56	19.00	26.92	2.22	0.32	0.00	0.00	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	54.17	33.89	26.33	21.79	4.24	0.61	0.30	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	48.61	18.10	12.93	19.13	13.45	1.03	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	44.50	15.28	12.62	25.24	12.62	1.33	0.00	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	38.74	10.77	14.11	15.39	14.88	0.51	0.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	51.13	21.73	6.39	13.55	27.61	0.51	1.53	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	45.43	23.47	18.93	9.84	31.05	0.76	0.76	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	54.78	20.50	9.75	13.11	27.22	1.01	0.34	0.34	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	113.27	76.80	25.84	57.96	6.76	1.69	1.21	0.72	0.97	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	114.09	67.29	22.73	42.34	4.90	1.34	3.57	0.45	0.00	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	111.22	79.03	29.27	55.61	5.85	1.95	2.93	0.00	0.49	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	58.68	22.00	18.64	28.12	1.83	0.31	2.14	0.31	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	227.73	78.08	22.77	16.27	3.25	0.00	13.01	0.00	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	73.80	32.76	12.58	20.52	3.97	0.99	0.66	0.99	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	43.78	14.78	9.30	28.46	12.04	0.00	1.09	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	48.85	15.92	13.75	18.82	14.48	0.36	0.72	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	48.75	14.59	12.10	17.08	9.61	0.00	0.71	0.36	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	39.38	17.90	4.77	16.71	33.41	0.00	1.19	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	60.26	17.06	7.31	9.62	28.30	1.49	0.95	0.14	0.00	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	49.84	17.78	9.16	11.05	30.71	0.00	0.81	0.00	0.00	0.27
immature langerhans cells, donor1	11904-125F5	100.01	58.84	38.99	8.96	18.89	11.38	0.48	0.24	0.00	0.73
immature langerhans cells, donor2	11905-125F6	49.11	60.99	34.06	3.17	21.39	8.71	0.00	0.00	0.79	0.79
insula, adult, pool1	10039-101F3	36.62	3.31	8.99	4.45	1.04	1.51	0.28	0.09	0.09	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	90.07	55.28	0.00	0.00	3.90	0.00	0.00	1.30	0.65	0.33
kidney, adult, pool1	10017-101C8	71.89	38.05	14.02	8.91	3.30	3.70	1.00	0.50	0.00	0.30
kidney, fetal, pool1	10045-101F9	74.20	33.81	17.47	25.39	11.95	3.75	0.14	0.21	0.00	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	68.60	46.87	0.00	0.00	1.70	0.00	0.00	0.00	0.85	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	78.66	40.09	8.71	3.73	1.38	0.14	0.41	0.55	0.41	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	45.87	38.35	12.84	11.74	8.07	1.28	0.18	0.18	1.28	0.18
left atrium, adult, donor1	10079-102A7	37.59	21.79	9.81	3.27	0.00	1.09	0.54	1.09	0.00	0.54
left ventricle, adult, donor1	10078-102A6	34.89	22.25	14.16	10.11	0.00	0.51	0.51	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	76.61	59.65	0.82	1.09	14.50	0.00	0.00	0.27	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	18.32	26.58	3.23	6.83	1.08	1.08	0.36	0.72	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	19.02	17.39	5.43	2.17	0.54	1.09	0.54	0.54	1.09	0.54
leiomyoma cell line:15425	10571-108B4	27.92	20.15	6.80	7.77	1.21	0.73	1.94	1.21	0.73	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	25.40	12.70	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	52.28	20.91	47.05	11.50	7.32	11.50	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	48.52	45.92	6.14	11.10	1.30	0.94	0.00	0.24	0.12	0.35
liposarcoma cell line:KMLS-1	10782-110G8	38.27	23.12	1.87	5.62	2.19	0.31	0.94	0.31	0.47	0.00
liposarcoma cell line:SW 872	10726-110A6	36.31	20.83	8.41	9.63	2.92	0.97	0.12	0.73	0.12	0.24
liver, adult, pool1	10018-101C9	64.01	71.79	16.04	13.29	0.65	5.35	0.32	0.32	0.00	0.00
liver, fetal, pool1	10086-102B5	34.81	29.16	9.41	26.34	0.00	2.82	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	33.25	12.98	18.81	4.81	13.56	6.42	0.44	0.15	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	55.00	18.27	14.21	6.64	7.57	6.64	1.48	0.74	0.00	0.37
locus coeruleus, adult, donor10258	10375-105G6	27.65	6.49	14.95	4.23	14.11	0.28	0.28	0.28	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	66.46	42.06	8.83	2.52	29.86	4.21	1.68	0.42	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	49.68	21.17	15.22	3.88	0.83	1.38	0.00	0.14	0.69	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	52.39	30.33	17.24	15.86	15.17	5.52	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	42.31	39.02	13.45	12.79	8.57	2.64	0.40	0.26	0.53	0.00
lung, adult, pool1	10019-101D1	65.44	46.54	21.26	8.15	14.06	2.60	0.12	0.35	0.00	0.35
lung, fetal, donor1	10068-101I5	83.34	48.80	19.12	13.41	67.07	2.00	0.86	0.00	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	45.82	24.29	19.70	11.46	10.08	0.46	0.92	0.46	0.46	0.92
lymph node, adult, donor1	10077-102A5	67.69	49.70	15.62	5.21	0.47	2.84	1.89	1.42	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	107.18	65.31	17.97	31.34	5.04	5.70	0.88	0.88	0.44	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	97.50	78.78	24.30	6.64	2.72	0.30	0.91	0.30	1.36	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	111.28	54.37	0.00	0.00	0.85	0.00	0.00	0.00	1.70	0.85
mature adipocyte, donor1	12231-129F8	38.18	23.98	23.98	3.55	1.78	24.42	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	36.11	18.68	10.38	5.81	2.49	20.55	0.00	0.00	0.21	0.00
mature adipocyte, donor3	12233-129G1	36.03	21.34	16.59	5.93	3.56	21.10	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	45.01	31.06	19.74	6.05	2.63	16.32	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	76.00	35.98	28.59	20.49	9.53	6.91	0.00	0.24	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	12.41	7.90	7.90	2.26	0.00	2.26	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	43.03	15.08	12.69	4.05	1.66	2.76	0.74	0.37	0.00	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	15.57	2.54	10.17	1.27	0.64	0.00	0.32	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	40.52	18.34	5.97	2.13	3.41	2.13	2.13	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	27.84	8.27	11.81	4.22	0.68	2.19	2.19	0.68	0.00	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	47.54	10.19	17.40	5.52	1.49	4.88	0.85	1.27	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	1.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	25.13	12.20	4.67	3.95	2.87	1.44	0.36	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	27.26	21.42	14.28	2.60	45.43	5.84	0.65	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	72.14	20.28	17.80	5.42	35.91	5.73	2.01	0.77	0.00	0.31
medulla oblongata, adult, pool1	10038-101F2	49.06	9.47	13.96	5.31	8.98	2.53	0.00	0.08	0.00	0.00
medulla oblongata, newborn, donor10223	10361-105F1	46.18	22.91	6.25	3.82	99.29	1.39	1.04	0.35	0.00	1.39
medulloblastoma cell line:D283 Med	10838-111E1	150.12	60.00	11.07	37.86	16.83	0.66	2.21	0.89	0.89	1.33
medulloblastoma cell line:ONS-76	10759-110E3	42.80	37.17	5.75	16.38	3.91	0.37	0.12	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	67.42	87.11	8.77	25.59	2.30	6.90	0.29	0.43	0.29	0.14
melanoma cell line:G-361	10465-106H6	33.93	42.08	2.17	4.61	1.63	3.26	0.27	0.81	1.36	0.27
meningioma cell line:HKBMM	10691-109F7	48.84	49.21	5.61	4.34	0.36	0.36	2.17	0.54	0.36	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	140.10	35.25	48.46	82.83	35.25	0.88	2.64	3.52	5.29	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	67.14	7.26	14.00	36.03	15.29	0.26	1.04	0.52	1.04	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	73.96	67.66	5.68	4.30	2.30	0.61	0.61	0.77	0.46	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	44.35	39.26	7.45	4.36	1.45	1.27	0.73	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	38.93	45.14	5.80	4.97	2.07	0.41	0.83	0.00	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	40.04	31.04	9.69	2.81	0.14	1.55	0.56	0.00	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	43.71	47.76	6.35	2.12	2.12	1.35	0.77	0.19	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	25.68	34.01	7.63	6.25	2.08	2.08	0.00	0.00	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	31.58	17.34	13.90	2.06	1.54	3.09	0.51	0.00	0.51	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	43.94	52.10	8.86	4.03	1.38	1.50	0.92	0.35	0.23	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	52.13	37.27	6.10	5.44	2.12	1.33	0.53	0.00	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	50.37	41.73	12.02	9.45	1.35	1.22	0.54	0.41	0.41	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	47.80	28.88	9.67	6.26	1.28	0.00	0.14	0.43	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	35.90	14.82	11.86	3.29	0.66	3.62	0.66	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	48.15	24.49	6.37	5.81	2.49	0.55	0.42	0.00	0.14	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	41.89	25.83	6.28	2.44	1.05	0.00	0.35	0.00	0.00	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.58	19.80	6.12	1.84	0.41	0.82	0.20	0.20	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	25.16	17.97	7.55	4.67	0.36	0.00	0.72	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	29.48	18.10	9.62	3.72	1.34	0.52	0.21	0.10	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.64	10.72	3.65	2.96	0.00	0.91	0.23	0.23	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	67.13	52.44	7.55	10.07	3.36	0.00	0.84	0.42	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	46.77	30.78	11.66	7.77	0.90	0.90	0.75	0.15	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	38.08	18.38	10.85	4.81	0.26	0.44	0.35	0.35	0.44	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	32.40	18.04	12.52	4.42	0.74	2.95	0.74	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	28.90	13.74	6.87	7.15	0.86	0.57	1.14	0.29	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	82.10	41.68	25.68	34.10	5.05	0.42	1.26	1.26	2.53	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	40.64	29.68	3.20	3.65	0.00	0.46	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	43.99	31.21	4.86	2.30	0.26	0.26	1.02	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	40.31	29.84	4.45	3.40	0.26	0.00	0.79	1.05	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	43.13	24.34	5.85	2.16	1.23	0.00	1.23	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	39.07	26.83	4.71	3.29	0.71	0.47	1.18	0.47	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	44.34	35.54	6.09	1.69	0.68	0.00	1.35	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	38.90	26.33	5.50	3.14	0.39	0.00	0.79	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	39.39	26.41	4.17	1.85	0.93	0.46	0.46	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	53.07	34.61	6.63	2.02	0.58	0.29	0.58	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	43.95	25.21	5.80	3.12	0.22	0.00	0.67	0.00	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	45.67	33.89	5.77	4.09	0.48	0.24	0.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.13	26.40	6.60	3.67	0.00	0.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	38.60	23.83	5.03	3.36	1.34	0.00	0.67	0.67	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	41.76	23.74	7.78	2.46	0.82	0.41	0.82	0.41	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	49.83	29.64	3.87	4.30	0.00	0.00	0.00	0.00	0.43	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	38.28	10.94	8.20	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	30.99	5.16	0.00	0.00	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	50.02	31.18	5.20	3.25	0.65	0.65	0.97	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	46.56	32.01	7.27	2.91	1.45	0.00	0.00	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	38.38	41.05	10.13	5.33	0.53	0.00	1.07	0.00	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	40.89	32.71	7.36	3.27	0.00	0.00	0.00	0.82	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	32.26	34.60	6.61	6.22	1.17	0.00	0.39	0.00	1.94	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	41.97	35.68	6.30	2.10	0.00	2.10	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	34.77	38.75	2.98	9.93	0.00	0.00	0.00	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	23.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	43.29	35.58	4.74	2.96	0.59	0.00	0.00	0.00	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	62.14	30.46	1.22	4.87	0.00	0.00	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	54.10	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	39.27	32.94	1.90	5.07	0.63	0.00	0.00	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	25.87	38.97	5.86	3.10	0.00	0.00	0.69	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	62.33	4.30	4.30	0.00	0.00	6.45	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	27.94	7.98	0.00	0.00	0.00	0.00	3.99	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	34.44	6.89	3.44	0.00	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	35.86	33.82	4.89	3.26	0.41	0.41	1.63	0.00	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.04	37.34	2.38	3.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	35.96	37.14	5.90	3.54	0.00	0.00	2.36	0.00	0.59	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	35.85	39.27	7.17	3.74	0.31	0.94	0.31	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	38.76	46.78	2.67	5.35	0.00	0.00	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	39.03	34.30	2.37	2.37	0.00	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	30.82	5.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	40.62	46.12	4.82	6.88	0.00	0.00	0.69	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	40.08	11.88	4.45	6.93	0.00	0.00	0.49	0.00	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	32.52	13.46	3.36	4.49	0.00	0.00	0.00	0.00	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	33.71	14.63	3.18	5.09	0.00	1.27	0.00	0.00	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	35.06	10.48	7.66	3.63	0.00	0.81	0.40	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	39.25	8.72	6.54	4.36	0.00	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	29.14	10.14	5.07	3.80	0.00	2.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.99	10.32	10.92	7.28	0.00	1.21	2.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	18.08	27.11	0.00	0.00	0.00	9.04	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	32.12	11.53	9.88	2.47	0.00	1.65	1.65	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	34.92	22.03	6.75	5.95	0.00	0.20	0.00	0.00	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	29.53	18.17	4.54	3.89	0.32	0.32	0.65	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	34.63	24.45	7.13	6.11	0.00	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	21.66	12.38	5.42	3.87	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	86.70	47.25	11.10	12.99	4.96	0.94	0.00	0.24	0.94	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	21.08	15.99	10.66	10.89	4.17	2.09	0.23	0.00	0.93	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	29.92	17.09	17.09	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	30.72	42.44	6.37	6.99	4.42	2.57	0.82	0.31	0.62	1.03
mesothelioma cell line:Mero-25	10850-111F4	35.40	30.18	4.99	5.67	7.04	0.45	0.91	0.45	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	57.21	33.00	7.82	9.53	5.38	1.22	0.73	0.73	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	65.54	35.43	10.63	9.96	1.77	0.89	0.66	0.44	0.22	1.77
mesothelioma cell line:Mero-82	10853-111F7	62.81	69.12	10.51	12.35	2.63	2.37	1.05	0.79	1.84	1.31
mesothelioma cell line:Mero-83	10854-111F8	49.02	37.28	11.23	14.13	10.04	1.36	0.68	1.02	0.68	0.85
mesothelioma cell line:Mero-84	10855-111F9	53.59	41.71	5.31	19.97	8.34	0.76	1.26	0.51	0.76	0.76
mesothelioma cell line:Mero-95	10856-111G1	55.69	48.45	9.73	14.70	4.97	0.41	1.66	0.62	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	62.12	41.08	11.26	16.90	4.80	0.00	0.66	0.99	0.17	0.83
mesothelioma cell line:NCI-H226	10846-111E9	58.46	58.82	13.57	18.10	7.24	1.09	1.99	1.45	0.18	1.27
mesothelioma cell line:NCI-H2452	10848-111F2	64.91	50.56	25.11	15.54	12.13	1.71	2.56	1.71	0.68	0.85
mesothelioma cell line:NCI-H28	10845-111E8	68.45	58.02	22.14	26.46	8.40	4.58	3.31	1.02	0.76	1.78
mesothelioma cell line:No36	10857-111G2	78.94	38.17	13.37	7.50	4.57	1.96	2.61	1.30	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	74.78	79.39	24.66	13.01	7.59	5.96	2.98	2.44	0.27	1.08
migratory langerhans cells, donor1	11901-125F2	60.46	31.09	2.11	1.15	11.71	0.38	0.96	0.19	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	48.85	18.32	3.18	3.05	5.86	0.00	0.73	0.12	0.00	0.49
migratory langerhans cells, donor3	11903-125F4	49.36	25.31	8.62	2.51	4.49	0.36	0.54	0.00	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	50.93	21.22	7.84	7.18	0.65	0.65	0.98	1.31	3.26	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	50.02	32.21	8.69	11.66	2.12	0.85	1.27	0.64	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	126.24	67.03	50.22	43.31	4.38	4.38	0.46	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	82.78	61.65	21.69	5.52	1.33	0.76	0.57	0.19	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	201.05	134.90	27.16	5.17	8.69	2.40	1.66	0.55	1.48	1.11
myeloma cell line:PCM6	10474-106I6	110.30	65.23	28.66	13.64	0.20	3.16	0.20	0.59	1.58	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	58.34	24.86	18.26	10.65	3.55	1.01	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	51.78	40.21	26.67	12.95	1.37	10.98	0.20	0.00	1.37	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	54.60	45.46	9.36	1.67	0.45	0.56	0.22	0.00	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	52.14	45.67	9.12	1.69	0.44	0.22	0.37	0.22	0.00	0.37
nasal epithelial cells, donor2	12227-129F4	101.01	57.96	10.49	3.31	2.21	1.10	1.66	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	47.16	15.41	9.66	41.18	0.69	0.46	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	118.99	55.94	22.26	35.92	6.92	1.50	0.19	0.37	0.75	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	55.25	27.63	4.01	8.44	4.22	0.00	0.00	0.63	1.48	0.63
neuroblastoma cell line:NH-12	10555-107I6	128.21	44.91	12.49	28.88	5.40	0.56	0.75	0.93	1.12	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	84.45	30.36	8.78	19.69	5.93	0.00	1.19	0.95	3.08	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	85.37	62.40	3.80	19.96	7.29	0.16	2.06	1.43	0.95	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	69.64	34.62	3.22	7.65	4.43	0.00	0.20	0.20	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.15	12.08	1.27	22.89	6.36	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	27.95	34.34	4.26	5.06	0.27	0.00	0.27	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	44.62	14.87	133.87	0.00	14.87	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	13.28	0.00	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	28.41	9.47	18.94	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	176.90	93.52	57.84	74.41	32.30	4.57	0.85	1.18	1.35	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	64.04	11.21	5.60	15.21	2.40	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	43.28	27.89	3.21	8.98	2.56	0.96	0.64	0.00	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	42.04	40.20	8.15	10.25	0.53	1.58	1.84	0.00	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	35.34	4.22	9.94	3.66	3.75	1.22	0.09	0.37	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	37.09	8.24	8.24	6.18	0.00	2.06	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	56.09	15.30	23.88	5.37	1.07	10.47	0.00	0.54	0.00	0.81
occipital cortex, newborn, donor10223	10355-105E4	29.48	13.10	5.82	2.91	2.18	1.82	0.36	0.00	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	25.45	1.84	7.35	6.30	0.52	0.52	0.00	0.26	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	51.92	3.00	8.58	20.17	4.29	0.43	0.43	0.86	0.86	0.86
occipital pole, adult, pool1	10036-101E9	29.09	2.68	9.07	4.10	0.63	1.34	0.08	0.24	0.00	0.08
olfactory region, adult	10195-103E6	27.13	3.06	7.45	4.20	3.06	1.53	0.38	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	30.02	0.00	22.01	30.02	8.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	183.73	175.76	0.00	0.00	18.68	0.23	0.57	1.03	1.25	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	172.97	148.93	14.43	19.37	6.46	1.92	0.55	0.82	0.82	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	97.19	96.35	4.57	4.23	4.40	0.00	1.52	1.02	1.02	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	93.79	145.31	0.00	0.00	10.28	0.00	1.27	0.69	1.73	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	42.04	12.35	6.76	2.94	2.65	0.00	0.59	0.00	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	57.93	45.78	14.02	5.61	1.87	2.80	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	111.12	46.23	0.00	0.00	3.61	0.00	0.00	0.42	0.21	0.42
ovary, adult, pool1	10020-101D2	91.28	54.16	7.42	4.45	10.83	0.79	0.17	0.35	0.00	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	30.06	21.82	0.00	0.00	1.83	0.00	0.00	0.18	0.55	0.18
pancreas, adult, donor1	10049-101G4	65.84	37.63	8.47	4.70	0.00	0.00	2.82	0.00	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	63.17	78.83	11.18	28.79	3.91	2.52	0.84	0.84	1.12	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	48.72	51.96	12.27	5.96	5.28	3.58	2.56	0.51	1.19	2.04
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	79.15	50.83	29.64	14.74	6.79	6.95	0.33	0.17	0.17	0.17
paracentral gyrus, adult, pool1	10035-101E8	33.77	3.57	8.42	5.77	0.46	1.19	0.00	0.09	0.00	0.09
parietal cortex, adult, donor10258	10373-105G4	26.42	2.20	8.81	1.47	0.73	0.00	0.00	2.20	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	28.21	8.46	13.17	3.76	0.00	2.82	0.00	0.00	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	46.18	14.54	13.97	4.28	1.14	3.14	2.28	0.57	0.00	0.29
parietal lobe, adult, pool1	10034-101E7	32.78	3.44	11.54	6.34	0.18	1.06	0.09	0.18	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	45.58	7.76	4.85	26.19	11.64	0.00	0.97	1.94	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	33.27	21.68	3.74	1.87	3.74	1.50	0.75	0.00	0.00	0.75
parotid gland, adult	10199-103F1	58.58	29.60	12.95	6.17	0.62	0.62	0.62	1.23	0.00	0.62
penis, adult	10200-103F2	56.93	16.11	14.50	6.98	1.07	0.00	1.61	1.07	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	95.94	86.27	1.67	2.05	2.79	0.00	1.49	0.56	1.86	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	51.72	34.68	11.07	15.01	2.19	1.17	0.29	0.58	1.17	0.87
pineal gland - adult, donor10196	10179-103C8	21.29	16.77	27.74	29.67	0.00	9.68	0.65	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	53.89	14.21	37.90	55.67	2.96	5.33	0.00	0.00	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	18.19	5.02	16.93	24.46	1.88	6.27	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	50.59	24.28	27.32	6.07	2.02	4.05	0.00	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	69.32	51.08	33.36	6.78	7.82	14.59	1.56	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	48.52	11.07	10.21	1.70	4.26	2.55	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	57.94	24.30	17.20	10.43	1.40	0.97	0.54	0.11	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	84.62	79.19	22.25	6.22	4.50	2.12	1.72	1.46	0.66	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	26.77	22.10	7.94	10.89	4.20	2.18	0.16	0.16	1.09	0.00
pons, adult, pool1	10033-101E6	35.98	4.65	9.81	5.77	1.55	0.69	0.09	0.09	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	33.74	2.88	8.37	3.92	0.52	0.87	0.17	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	131.76	79.47	64.83	14.64	48.10	6.27	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	82.62	66.10	5.51	11.02	27.54	0.00	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	58.68	0.00	0.00	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	102.84	91.18	18.94	25.93	8.01	1.89	1.17	0.15	1.02	0.44
prostate cancer cell line:PC-3	10439-106E7	135.40	41.93	21.42	44.47	4.36	3.45	0.00	0.54	1.45	0.36
prostate, adult, pool1	10022-101D4	57.77	30.93	13.60	13.42	0.36	1.54	0.36	0.09	0.00	0.00
putamen, adult, donor10196	10176-103C5	33.28	8.97	11.09	3.54	3.30	6.14	0.24	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	27.45	25.49	5.88	3.92	1.96	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	29.51	25.13	3.28	4.37	4.37	0.00	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	23.92	0.97	7.73	2.90	0.24	0.97	0.48	0.48	0.00	0.00
putamen, newborn, donor10223	10365-105F5	74.97	38.98	6.75	2.25	1.50	1.50	1.50	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	103.86	113.17	21.82	12.22	7.27	10.18	0.00	0.00	0.87	0.58
rectum, fetal, donor1	10067-101I4	58.42	27.82	9.74	44.51	4.17	1.39	0.00	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	35.40	27.14	6.78	6.15	6.15	0.64	0.42	0.21	1.48	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	57.99	36.86	1.24	11.18	17.81	1.24	0.83	0.41	2.07	0.41
retina, adult, pool1	10030-101E3	53.38	15.71	16.10	20.48	0.70	2.09	0.20	0.40	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	93.53	40.79	28.84	67.81	22.08	2.34	0.78	0.52	3.12	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	67.99	44.14	14.26	19.79	17.34	0.61	0.37	0.12	0.86	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	78.74	57.08	15.18	43.30	4.50	1.41	0.28	0.00	0.28	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	24.25	20.46	6.82	9.09	0.00	1.52	0.00	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	46.45	53.57	4.37	1.13	1.29	0.65	1.29	0.32	0.65	0.16
salivary acinar cells, donor2	11772-123I8	47.92	45.44	7.02	3.99	0.96	0.28	0.96	0.83	0.14	0.83
salivary acinar cells, donor3	11773-123I9	29.79	26.48	19.86	16.55	0.66	1.32	0.66	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	52.62	17.16	17.16	13.15	0.00	0.00	0.00	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	86.59	53.28	20.57	10.88	4.64	6.49	0.34	0.17	0.51	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	88.63	53.13	19.16	11.64	5.41	8.11	0.71	0.47	0.82	0.35
seminal vesicle, adult	10201-103F3	41.80	11.11	16.93	12.70	1.06	1.06	1.59	0.53	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	31.58	31.34	8.75	8.02	17.00	2.19	0.49	0.49	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	50.83	29.94	10.82	7.55	2.01	1.01	0.50	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	76.27	42.15	8.03	15.05	4.01	0.00	0.00	0.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	67.83	56.28	15.04	20.42	41.37	2.28	0.67	0.94	0.40	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	70.74	67.53	21.77	25.20	7.96	4.75	0.33	0.11	0.77	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	70.45	79.87	17.03	22.19	6.06	2.45	0.39	0.52	0.90	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	30.50	7.80	11.35	3.55	0.00	0.71	0.00	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	68.12	35.14	16.43	4.08	0.36	1.92	0.48	0.00	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	49.25	14.07	12.06	7.04	1.01	2.01	1.01	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	81.42	40.71	6.79	74.64	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	58.07	25.25	8.84	23.36	1.26	1.26	0.00	3.16	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	70.71	39.02	48.03	53.36	14.01	6.67	0.33	0.67	1.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	71.24	34.36	40.35	42.87	17.34	5.36	2.21	2.84	1.26	2.84
small cell lung carcinoma cell line:DMS 144	10841-111E4	136.66	17.15	13.69	34.31	8.67	1.35	0.77	0.39	0.39	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	66.92	33.95	0.00	0.00	1.15	0.00	0.33	0.00	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	83.96	23.48	5.95	41.98	2.41	0.48	1.13	0.97	0.32	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	55.35	28.11	29.42	29.85	9.59	7.41	0.44	0.22	0.65	0.00
small intestine, adult, pool1	10024-101D6	92.57	66.77	22.34	25.68	1.19	24.49	0.48	0.96	0.00	0.48
small intestine, fetal, donor1	10064-101I1	71.50	54.05	14.25	25.06	6.63	13.51	2.70	6.63	0.25	2.70
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	36.93	41.54	16.93	45.14	40.01	2.56	2.56	0.00	1.03	2.05
smooth muscle, adult, pool1	10048-101G3	70.82	30.50	6.72	7.24	0.52	0.52	1.03	1.55	0.26	0.52
somatostatinoma cell line:QGP-1	10781-110G7	57.09	31.63	28.14	26.27	0.54	5.09	0.00	0.27	0.27	0.54
spinal cord - adult, donor10196	10181-103D1	50.70	29.59	26.61	6.19	0.46	8.72	0.92	0.92	0.00	0.46
spinal cord, adult, donor10252	10159-103A6	61.90	31.54	23.26	3.94	0.79	4.73	0.39	0.79	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	22.14	5.53	11.76	0.00	3.46	1.38	1.38	1.38	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	56.10	10.37	11.59	20.12	2.44	1.83	0.61	0.00	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	60.62	28.47	8.73	1.84	9.64	2.76	1.84	1.38	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	33.01	26.29	9.86	6.87	1.79	0.75	0.00	0.00	0.00	0.15
spleen, adult, pool1	10025-101D7	86.68	55.73	29.74	6.61	0.44	2.97	0.22	0.55	0.00	0.22
spleen, fetal, pool1	10044-101F8	92.96	58.88	24.95	12.71	1.99	5.96	0.48	0.16	0.08	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	74.74	63.97	19.87	4.76	12.52	1.14	0.41	0.31	0.93	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	40.44	23.16	0.00	0.19	1.71	0.00	0.00	0.00	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	65.70	43.33	25.86	30.05	12.23	2.10	2.45	2.10	6.29	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	101.64	97.73	0.00	0.00	3.52	0.00	0.39	0.00	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	162.31	107.72	30.95	16.55	11.26	4.84	0.90	0.79	2.03	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	52.53	37.70	4.24	8.90	2.54	0.00	0.00	0.85	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	57.96	32.15	30.46	12.27	4.65	6.35	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	50.19	25.63	12.82	22.43	1.07	6.41	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	70.07	21.08	9.68	6.84	0.57	0.00	0.57	1.71	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	74.77	22.22	20.56	10.18	1.66	7.27	2.08	1.45	0.00	0.83
substantia nigra, adult, donor10258	10371-105G2	11.90	3.62	5.17	3.62	3.62	1.55	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	49.46	27.56	14.84	8.48	2.12	2.12	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	146.27	45.17	14.21	15.82	8.25	0.46	0.92	0.23	1.83	0.69
temporal lobe, adult, pool1	10031-101E4	31.20	3.14	9.41	4.24	1.36	0.76	0.34	0.08	0.00	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	59.12	2.85	9.97	29.92	4.27	2.14	0.00	1.42	0.71	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	55.82	9.23	8.35	13.19	3.96	0.00	0.44	1.76	0.00	0.44
tenocyte, donor1	11763-123H8	49.57	48.87	3.14	4.54	1.05	0.00	3.84	1.05	0.00	2.44
tenocyte, donor2	11765-123I1	36.24	45.02	5.72	1.53	0.76	0.76	1.53	0.00	0.38	1.14
tenocyte, donor3	11768-123I4	40.03	44.85	5.19	4.45	1.48	0.74	2.22	1.11	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	90.42	68.66	6.29	67.47	12.75	0.85	1.53	3.74	2.38	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	114.07	42.70	0.00	0.00	6.63	0.00	1.39	1.54	1.70	0.77
teratocarcinoma cell line:PA-1	10807-111A6	86.17	28.83	0.00	0.00	1.08	0.00	0.62	0.77	0.77	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	73.25	83.15	9.27	57.89	7.62	1.27	0.63	0.89	1.78	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	92.65	103.24	7.19	42.36	9.08	0.76	1.13	0.38	1.51	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	51.80	79.62	2.94	47.11	4.80	1.85	0.33	0.44	1.09	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	97.06	90.22	7.17	31.59	16.29	0.65	5.21	1.95	3.26	0.98
testis, adult, pool1	10026-101D8	63.78	26.63	10.09	6.12	79.89	1.18	0.86	0.32	0.00	0.32
testis, adult, pool2	10096-102C6	80.74	22.55	12.63	10.83	225.09	0.00	3.16	2.71	0.45	1.35
thalamus - adult, donor10196	10168-103B6	30.91	15.46	22.08	5.52	6.62	8.83	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	82.36	15.16	20.32	7.50	4.22	4.84	1.88	1.09	0.00	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	3.08	1.54	6.16	20.02	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	20.09	3.29	7.74	4.12	7.74	1.32	0.33	0.33	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	33.37	19.56	3.45	0.58	1.15	0.00	0.58	0.00	0.00	0.00
throat, adult	10209-103G2	46.94	25.47	12.98	5.49	5.74	0.75	0.50	0.75	0.00	0.25
throat, fetal, donor1	10061-101H7	57.28	24.99	11.27	21.63	16.15	2.44	0.91	0.61	0.00	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	110.49	89.03	1.99	1.79	31.60	0.20	1.39	0.99	0.60	0.20
thymus, adult, pool1	10027-101D9	135.60	54.28	29.33	36.58	12.13	0.40	0.89	0.89	0.20	0.10
thymus, fetal, pool1	10043-101F7	100.27	46.55	27.43	29.30	8.31	1.66	0.42	0.10	0.10	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	51.72	32.44	4.79	2.13	1.99	0.53	0.40	0.27	0.53	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	63.42	37.02	17.18	13.27	7.82	1.40	0.42	1.12	0.00	0.42
thyroid, adult, pool1	10028-101E1	84.73	38.07	16.61	6.63	1.49	1.49	0.28	0.00	0.19	0.19
thyroid, fetal, donor1	10060-101H6	64.33	13.18	12.13	11.34	3.69	0.53	0.53	1.05	0.79	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	24.64	12.32	12.32	3.08	6.16	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	62.80	40.24	11.40	4.65	0.93	0.23	2.33	1.16	0.00	0.93
tongue, fetal, donor1	10059-101H5	62.27	16.16	11.03	11.03	1.18	0.79	1.97	2.36	0.00	1.58
tonsil, adult, pool1	10047-101G2	111.19	67.12	27.85	13.92	3.11	1.40	0.20	0.40	0.00	0.30
trachea, adult, pool1	10029-101E2	67.32	51.12	12.43	5.56	41.88	1.88	0.65	0.41	0.00	0.08
trachea, fetal, donor1	10058-101H4	76.94	49.63	14.23	15.77	10.77	0.38	1.92	1.92	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	46.76	43.22	5.31	8.15	2.48	0.00	0.71	0.00	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	40.43	35.66	12.87	16.92	2.43	2.13	0.30	0.10	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	186.14	165.30	54.21	41.68	30.08	7.36	1.57	1.25	4.07	0.78
tridermal teratoma cell line:HGRT	10694-109G1	28.54	39.95	11.42	19.03	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	53.16	38.09	13.04	20.32	1.52	3.30	0.25	0.76	0.51	0.17
umbilical cord, fetal, donor1	10057-101H3	62.60	10.43	6.26	8.35	8.35	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	70.13	29.86	10.58	9.90	1.88	1.02	1.02	0.51	0.17	0.17
uterus, fetal, donor1	10055-101H1	65.01	31.23	8.19	20.99	7.17	0.00	1.02	0.00	0.00	0.00
vagina, adult	10204-103F6	67.85	57.51	20.68	5.82	2.58	8.40	0.65	0.00	0.65	0.65
vein, adult	10191-103E2	73.65	40.99	21.92	9.21	0.44	1.53	1.53	0.44	0.44	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	51.27	48.87	16.56	5.34	3.20	1.07	1.07	0.53	1.07	0.00